1. Regional Clinical Hospital № 2, Krasnodar 350012, Russia

Abstract:The relevance of milk-feeding of babies, the importance of not only the composition and properties of breast milk, but also the technology of enzymatic degradation of its nutrients are cosidered In the Assembly speech. First, it is produced according to the type of its own digestion by hydrolases of the digestive glands and the small intestine of the infant, the complex of which is formed antenatally and called the starting multienzyme digestive potential in the newborn child. Its quantitative characterization is possible by determining the main digestive hydrolases in the amniotic fl uid, in the blood of the umbilical cord and in the gastric aspirate of the infant. The expression of this potential in the point system is proposed. With incomplete gestation, the digestive potential is reduced. Secondly, hydrolysis of breast milk nutrients is carried out by its own hydrolases in the autolytic type of digestion. The dynamics of secretion of hydrolases by the mammary glands of healthy women during one year of lactation was studied. The quantitative dependence of the hydrolase secretion on its value in the fi rst lactation month is described with a general tendency to a decrease in the hydrolase content in milk with an increase in the monthly lactation period, and the dependence of the secretion of enzymes by the mammary glands from the age of the pregnant women. The dynamic convergence of the multienzyme digestive potentials of the child's digestion system and the mother's milk it takes is relevant in lactotrophy. Based on the results of peptidic analysis of auto-and inragastral proteolysis of breast milk, milk hydrolases are not only considered as trophotropic participants in the degradation of its nutrients, but also in formation of by milk proteases functionally multipotent regulatory peptides with a characteristic change in their number and content in the dynamics of infant feeding and timing of gestation.

• References total 82 ⇓ :: .
  1. Arshavsky I. A., Nemets M. P. On the change of types of nutrition and digestion in ontogenesis. Advances of Physiological Sciences. 1996, vol.27, no.1, pp. 109–129.
  2. Kapitan T. V. Propedevtika detskikh boleznei s ukhodom za det’mi. M.: MEDpressinform; 2009, 657 p. (in Russian)
  3. Korot’ko G. F. Sistema pishhevarenija i tipy pitanija v ontogeneze. Krasnodar: “Tradicija”, 2014, 176 p. (In Russ.)
  4. Ugolev A. M. Digestive evolution and principles of function evolution. Th e elements of modern functionalism. Leningrad: Nauka; 1985. 544p. (in Russian)
  5. Ugolev A. M., Tsvetkova V. A. Induced autolysis as important mechanism of initial digestive stages in natural conditions. Fiziologicheskiy zhurnal SSSR im. I. M. Sechenova. 1984; 70(11): 1542–50. (in Russian)
  6. Maslov M. S. Textbook of pediatric diseases. L.: Meditsina, 1953.512 p.
  7. Albrecht T. W., Iaynes H. O. Milk Lipase // J. Dairy Sci. 1955. V. 38. N2. P. 137–146.
  8. Chandan K. C., Shahani K. M. Purifi cation and characterization of milk lipase // I. Purifi cation // J. Dairy Sci. 1963. V. 46. N4. P. 275–283.
  9. Fanaroff A. A., Martin R. Y. (Ed.) / Neonatal-Perinatal Medicina / Mosby. 2002. 1732 p.
  10. Hamosh M. Bioactiv Components in Human Milk // Pediatric. Basics. 2002. N99. P. 2–11.
  11. Adamkin D. H. Feeding strategy of newborns with very low body mass in birth. Trans. from English by Baibarina E. N. Moscow: GEOTAR-Media; 2013. 176p. (in Russian)
  12. Arshavsky I. A. Lipase of mother’s milk and its value in connection with the assessment of the negative aspects of artifi cial feeding. Pediatrics. 1940, no. 4, pp. 11–13
  13. Brockerhoff H., Jensen R. Lipolytic Enzymes: English transl. M.: Mir, 1978, 396 p.
  14. Volodin N. N. (gl. red.) Neonatologija. Nacional’noe rukovodstvo. M.: GEOTAR-Media, 2007, 848 p. (In Russ.)
  15. Hamosh M. Enzymes of human milk // Handbook of milk composition / Ed. R. Jencen. N. – Y.; Academic Press, 1995. P. 388–427.
  16. Shirina L. I., Mazo V. K. Sistema pishhevarenija rebenka, ee sozrevanie. Tuteljan V. A., Kon’ I. Ja. Detskoe pitanie. Rukovodstvo dlja vrachej, 2009. Ch. I, gl. 3: 25–50. (In Russ.)
  17. Shabalov N. P. (gl. red.) Neonatologiya – 4-e izd. [2-h t.]. M.: MEDpress-inform, 2006, 344 p. (In Russ.)
  18. Penzhoyan G. A., Model’ G.YU., Korot’ko G. F. Zakonomernost’ formirovaniya u novorozhdennyh detej digestivnogo startovogo potenciala. Diplom na otkrytie No499 ot 27.08.2017. registracionnyj No648. (In Russ.)]
  19. Volodin N. N. (gl. red.) Neonatologija. Nacional’noe rukovodstvo. M.: GEOTAR-Media, 2007, 848 p. (In Russ.)
  20. Baranov A. I., Klimanskaya G. V., Rimarchuk G. V. Detskaya gastroehnterologiya. M., 2003, 1029 p. (In Russ.)
  21. Tutelyan V. A. Pediatric nutrition. Manual for physicians (eds.: V. A. Tutelyan, I. Ya. Kon’). M.: LLC “Meditsinskoye informagentstvo”, 2009. 952 p.
  22. Korot’ko G. F. Types of digestion in breast feeding: returning to the problem. Problems of Nutrition. 2016, vol. 85, no.1, pp.19–28.
  23. Ugolev A. M. Natural technologies of biological systems. Saint Petersburg, Science Publ., 1987, 317 p.
  24. Ugolev A. M. Evolution of digestion and principles of evolution of functions. Elements of up-to-date functionalism. L.: Nauka, 1985. 544 p.
  25. Dallas DC, Guerrero A, Khaldi N, Borghese RA, BhandariA, Underwood MA et al. A peptidomic analysis of human milk digestion in the infant stomach reveals protein-specifi c degradation patterns // J. Nutr., 2014: 144(6). P. 815–820.
  26. Dallas DC, Murray NM, Gan J. Proteolytic systems in milk: perspectives on the evolutionary function within the mammary gland and the infant // J. Mammary Gland Biol Neoplasia. 2015 Dec; 20(3–4). P. 133–147.
  27. Dallas DC, Underwood MA, Zivkovic AM, German JB. Digestion of protein premature and term infants // J. Nutr. Disord. Th er. 2012: 2(3). P. 112–121.
  28. Ferranti P, Traisci MV, Picariello G, Nasi A, Boschi V, Siervo M et al. Casein proteolysis inhuman milk: Tracing the pattern of casein breakdown and theformation of potential bioactive peptides // J. Dairy Res. 2004. P. 71 (01), 7 4–87.
  29. Hamosh M. Enzymes of human milk // Handbook of milk composition / Ed. R. Jencen. N. – Y.; Academic Press, 1995. P. 388–427.
  30. Holton TA, Vijaykumar V, Dallas DC, Guerrero A, Borghese RA, Lebrilla CB et al. Following the digestion of milk proteins from mother to baby // J. Proteome Res. 2014. P. 13(12): 5777–5783.
  31. Kelly AL, O’Flaherty F, Fox PF. Indigenous proteolyticenzymes in milk: A brief overview of the present state of knowledge //Int. Dairy J. 2006. P. 16 (6), 563–572.
  32. Khaldi N, Vijayakumar V, Dallas DC, Guerrero A, Wickramasinghe S, Smilowitz JT et al. Predicting the important enzyme playersin human breast milk digestion // J. Agric. Food Chem. 2014. P. 62 (29),7225–7232.
  33. Silanikove N, Merin U, Leitner G. Physiological role ofi ndigenous milk enzymes: An overview of an evolving picture // Int. Dairy J. 2006. P. 16 (6), 533–545.
  34. Korotko G. F. Feeding and digestion on the earlier periods of human ontogenesis. Krasnodar: Tradition; 2016. 86p. (in Russian)
  35. Korotko G. F. Recurculation of digestive glands enzymes. Krasnodar: Publ. “EDVI”; 2011. 144p. (in Russian)
  36. Salaspuro M, Sipponen P, Sugano K, Sung J. Rationaleindiagnosisandscreening of atrophic gastritis with stomash-specifi c plasma bionarkers // Scand. J. Gastroenterol. 2012. P. 47(2), 136–147.
  37. Tzapok P. I., Drozdov V. N. Amniotic fl uid in system “Mother – placenta – fetus”. Kemerovo: Book publishers; 1986. 103p. (in Russian)
  38. Penzhoyan G. A., Model G. Yu., Korotko G. F., Khorolskii V. A. Amniotic fl uid hydrolase in newborn complex characteristics. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (1): 66–70. (in Russian) http://dx.doi.org/10.18565/aig.2017.1.66–70
  39. Kolodkina E. V., Kamakin N. F. Gomeostaz inkretiruyemykh fermentov u zhenshchin pri beremennosti i v period grudnogo vskarmlivaniya [Homeostasis of Incremental Enzymes in Women During Pregnancy and During Breastfeeding]. Kirov, Kirov State Medical Academy Publ., 2008. 156 p.
  40. Kolodkina Ye.V., Kamakin N. F. Enzyme homeostasis in women at pregnancy, in relation to term and type of delivery. Kirov: Kirov SMA, 2008. 111 p.
  41. Kulik V. P., Shalygina N. B. Morphology of the small intestine: Manual on physiology. L.: Nauka, 1977. P. 5–81.
  42. Arshavsky I. A., Nemets M. P. On the change of types of nutrition and digestion in ontogenesis. Advances of Physiological Sciences. 1996, vol.27, no.1, pp. 109–129.
  43. Rakhimov K. R. Mechanisms of lactose assimilation in human and animal ontogenesis. Tashkent: Ed. “FAN” UzSSR AS, 1991. 136 p.
  44. Korot’ko G. F. Digestivnyj i reguljatornyj jeff ekty lipoliticheskoj aktivnosti himusa. Klinich. medicina. 2001; 11: 8–12. (In Russ.)
  45. Penjoyan G. A., Model’ G. Yu., Korot’ko G. F. Evaluation of the starting multienzyme digestive potential of newborns. Guidelines. Krasnodar. EDVI Publ., 2018, 44 p.
  46. Ostroumova T. A. Himiya i fi zika moloka. Uchebnoe posobie. Kemerovo Izd. KTIPP, 2004, 196 p. (In Russ.)
  47. Zakharova I. N., Dmitrieva Y. A., Gordeeva E. A. Milk fat globule membrane: Innovation discoveries just for today. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2015;60(6):15–21.
  48. Komarova O. N., Khavkin A. I. The milk fat globule membrane: Technology of the future is just today. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2016;61(2):35–41. (In Russ.) https://doi.org/10.21508/1027–4065–2016– 61–2–35–41
  49. Korot’ko G. F. Pishhevarenie pri grudnom vskarmlivanii detej (jenzimologicheskie akcenty). Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologii. 2015; 25 (3): 12–20 (In Russ.)
  50. Korot’ko G. F. Autologous and autolytic digestion in lactotrophy. Journal of Fundamental Medicine and Biology. 2017, no. 3, pp. 3–13.
  51. Ugolev A. M., Timofeeva N. M., Gruzdkov A. A. Adaptacija pishhevaritel’noj sistemy. Fiziologija adaptacionnyh processov: Ruk. po fi ziologii. M., Nauka, 1986, pp. 371– 480. (In Russ.)
  52. Nielsen S.D, Beverly R. L., Qu Y., Dallas D. C. Milk bioactive peptide database: A comprehensive database of milk protein-derived bioactive peptides and novel visualization. / Food Chemistry 232(2017). P. 673–682.
  53. Dallas D. C., German J. B. Enzymes of human milk. Nestle Nutr Inst Workshop Ser. 2017; 88. P. 129–136.
  54. Demers-Mathieu V., Nielsen S. D., Underwood M. A., Borghese R., Dallas D. C. Analysis of milk from mothers who delivered prematurely reveals few changes in proteases and protease inhibitors across gestational age at birth and infant postnatal age // J. Nutr., 2017; 147(6). P. 1152–1159.
  55. Rodrigues LR. Milk minor constituents, enzymes, hormones, growth factors, and organic acids. 2013. p. 1–60.
  56. Dallas DC, Smink CJ, Robinson RC, Tian T et al. Endogenous human milk peptide release is greater aft er preterm birth than term birth. J Nutr 2015 Mar;145(3). P. 425–33.
  57. Shaternikov V. A. Proteolytic activity and trypsin inhibitor content in blood serum and pancreatic juice at chronic pancreatitis. Vopr med khimii 1966; 12, issue 1:103–5.
  58. Hirsihowitz B. I. Th e control of pepsinogen secretion // Ann. Acad. Sci. 1967. V. 140. N4. Р. 709–23.
  59. Ugolev A. M., Iyezuitova N. N., Masevich Ts.G. et al. Investigation of human digestive system (Review of modern methods). L.: Nauka, 1969. 216 p.
  60. Abdullayev F. A. Modifi ed method of assessment of lipolytic activity of digestive secretions: abstracts of the Second Republic conference on clinical biochemistry. Tashkent, 1965. P. 45–8.
  61. Korot’ko G.F., Mirzakarimov U. M. O gidrolazakh grudnogo moloka. Vestnik intensivnoi terapii. 2014; 5: 75–80.
  62. Korot’ko G. F. Sekretsiya podzheludochnoy zhelezy [Secretion of the Pancreas]. 2nd ed. Krasnodar, KSMU Publ., 2005. 312 p.
  63. Rothman S., Liebow C., Isenman L. C. Conservationofdigestiveenzymes // Physiol. Rev. 2002; (82). P. 1–8.
  64. Serov V. N., Strizhakov S. A., Markin S. A. Prakticheskoe akusherstvo. Rukovodstvo dlya vrachei. M.: Meditsina. 1989, 512 p.
  65. Shahani K. M. Milk Enzymes: their role and significance // J. Dairy Sci. 1966. V. 8. P. 907–920.
  66. Hernell O. Human milk vs. Cow´s milk and the evolution of infant formulas. Nestle Nutr Inst Workshop Ser Pediatr Program, 2011. (67). P. 17–28.
  67. Neville M. C. Milk secretion: an overview // mammiary. nih.gov / reviews / lactation / Neville 001/21.09.2000.
  68. Korot’ko G. F. Hydrolase of breast milk in neborn lactotrophy. Journal of Fundamental Medicine and Biology. 2018, no. 2, pp. 3–12.
  69. Morozov I. A. Vesicular Intracellular Transport In Th e Digestive Organs. Membrane Vesicle – Th e Universal Mechanism Of Th e Functional Transport. Experimental and Clinical Gastroenterology. 2014, vol.102, no. 2, pp. 3–15.
  70. Degtyaryov В., Degtyareva T. V. Milk amylolytic activity: Abstr. I conf. biochem. Middle Asia, Kazakhstan. Tashkent, 1966. P. 128.
  71. Shcherbakov A. Y., Ue Si. Peculiarities of lactation function in puerpera. Mezhdunarodnyiy meditsinskiy zhurnal. 2008; 4: 56–59. (in Russian)
  72. Foundations of Peptide Regulation of the Physiological Functions: Blood-Brain Barrier and Evolution of Viscerato-Brain Communications by Alexander T. Maryanovich
  73. Korotko G. F. Proteolysis in regulation of function functions of the digestion system. Experimental and Clinical Gastroenterology. 2013, no. 10, pp. 23–27.
  74. Penjoyan G. A., Model’ G. Yu., Korot’ko G. F. Initial digestive potential of newborn Gastro-intestinal system. Journal of Fundamental Medicine and Biology. 2017, no. 2, pp. 20–27.
  75. Kharkova R. M. Digestive function in fi rst year infants at various nutrition types. Vopr pitaniya i vospitaniya detey. 1968. P. 17–27.
  76. Kharkova R. M. Adaptation of the function of digestion to qualitatively diff erent food of children of the fi rst year of life. Adaptation and compensatory mechanisms in the pathology of childhood: Collection of scientifi c Works. Moscow, 1972, pp. 39–41
  77. Rodriguez JM. Th e human milk microbiota. Pediatrics (Suppl.). 2016; 4. P. 35–40.
  78. Korotko G. F. Recretion of Ferments and Hormones by Exocrinal Glands. Advances of Physiological Sciences. 2003, vol.34, no.2, pp. 21–32.
  79. Grachev I. I., Galancev V. P. Fiziologiya laktacii, obshchaya i sravnitel’naya. Rukovodstvo po fi ziologii. L.: Nauka, 1973, 590 p. (In Russ.)]
  80. Del Aguila EM, Flosi Paschoalin VM, Silva JT, Conte-Junior CA. Functional Aspect of Colostrum and Whey Proteins in Human Milk. J Hum Nutr Food Sci. 2014. 2(3). P. 1035–1044.
  81. Wagner CL, Julie RD, Considerations in meeting protein needs of the human milkfed preterm infant. Advances in Neonatal Care: August 2014, 14(4). P. 281–289.
  82. Haschke F, Haiden N, Th akkar SK. Nutritive and bioactive proteins in breastmilk. Ann Nutr Metab. 2016; 69(2). P. 17–26.

Full text is published :
Korot’ko G. F. Lactotrophy of infants in terms of digestiology (Assembly speech). Experimental and Clinical Gastroenterology. 2019;161(1): 4–54. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-4-54
Read & Download full text

1. Pirogov Russian National Research Medical University (RNRMU), Moscow 117997, Russia

Keywords: children, intestinal microfl ora, microbiota, мicrobiome, humus, probiotics, рrebiotics, metabiotiсs, synbiotics, autometabiolites.

Abstract:Microbiota plays a key role in the physiology and maintenance of homeostasis of the human body. The importance belongs to the processes of the formation of the intestinal microbiota, starting in utero, and the child continues to receive the mother’s microfl ora during childbirth and breastfeeding. The results of molecular genetic studies indicate that the most intensive process of microbial colonization in infant is associated with features of feeding. The main factor in maintaining the stability and resistance of normal biota is microbial autometabiolites. Considered the most promising probiotic biotechnology and development metabolic of probiotics (metabiotics) probiotics in combination with Prebiotics (synbiotics). Understanding the processes of formation of intestinal microfl ora allows you to develop eff ective methods of prevention and correction micro-ecological and motor disorders in the age aspect.

• References total 35 ⇓ :: .
  1. Dietert R. (Дитерт Р.) Человеческий суперорганизм. М.: КоЛибри, Азбука-Аттикус, 2016: 416 с.
  2. Falkowski P. G. (Фальковски П.) Двигатели жизни: как бактерии сделали наш мир обитаемым. М.-СПб: Питер, 2016: 270 с.
  3. Kozhevnikov A. A., Raskina K. V., Martynova E. Yu. et al. Intestinal microbiota: modern concepts of the species composition, functions and diagnostic techniques. RMJ. 2017, no. 17, pp. 1244–1247 (in Russ)
  4. Landman C., Qmvrain E. Gut microbiota: Description, role and pathophysiologic implications. Rev Med Interne. 2016; 37 (6): 418–423. DOI:10.1016/j.revmed. 2015.12.012.
  5. Yakushin A. S., Denisov M. Yu. Infl uence of intestinal microbiota on the immune system of the child in the fi rst thousand days of life and the possibility of probiotic correction. Pediatrics (Suppl. Consilium Medicum). 2018, no. 2: pp. 43–46. DOI: 10.26442/2413–8460_2018.2.43– 46 (in Russ)
  6. Koleva P, Kim J, Scott J. Kozyrskyj A. Microbial programming of health and disease starts during fetal life. Birth Defects Res С Embryo Today 2015; 105 (4): 265–277.
  7. Aagaard K., Ma J., Antony K. M., Ganu R., Petrosino J., Versalovic J. Th e placenta harbors a unique microbiome. Sci Trans Med. 2014; 6: 237–239. DOI: 10.1126/ scitranslmed.3008599
  8. Marchesi J. R., Adams D. H., Fava F., Hermes Hirschfi eld G. M., Hold G. et al. Th e gut microbiota at health: A new clinical frontier. Gut. 2016; 65: 330–339 10.1136/gutjnl-2015–309990.
  9. Bondarenko VM, Ryabichenko EV. Intestinal-brain axis. Neuronal and immune-infl ammatory mechanisms of brain and intestine pathology. Zh MikrobiolEpidemiolImmunobiol. 2013;(2):112–120. (In Russ).
  10. Cong X., Xu W., RomisherR., Poveda S., Forte S., Starkweather A. et al. Gut Microbiome and Infant Health: Brain-Gut – Microbiota Axis and Host Genetic Factors. Yale J Biol Med 2016; 89 (3): 299–308.
  11. Eckburg P.B., Bik E. M., Bernstein C. N., Purdom E., Dethlefsen L., Sargent M. Diversity of the human in microbial fl ora. Science. 2005; 308 (5728):1635–1638. DOI: 10.1126/ science.1110591
  12. Korotkij N. G., Narinskaja N. M., Bel’mer S.V., Ardatskaja M. D. Microbiotheria and motor disorders of the gastrointestinal tract in severe atopic dermatitis in children.Experimental and Clinical Gastroenterology Journal 2016, vol. 125, no. 1, pp. 21–27. (in Russ)
  13. Kоstic A. D., Xavier R. J., Gevers D. Th e microbiome in infl ammatory bowel disease: current status and the future ahead. Gastroenterology. 2014; 146 (6):1489–1499. DOI: 10.1053/j. gastrо.2014.02.009
  14. Shenderov B. A. Mikrobnaya ekologiya cheloveka i ee rol v podderzhanii zdorovya // Metamorfozy. 2014, no. 5. pp. 72–80 (in Russ)
  15. Wang X., Li G. H., Zou C. G. et al. Bacteria can mobilize nematode-trapping fungi to kill nematodes. Nat. Commun.2014; 16: 5776. DOI: 10.1038/ncomms6776
  16. Buharin O. V., Perunova N. B. Mikrosimbiocenoz [Microbiocenosis]. Ekaterinburg: UrO RAN. 2014. 260p
  17. Ohland C. L., Jobin C. Microbial activities and intestinal homeostasis: a delicate balance between health and disease. Cell Mol Gastroenterol Hepatol. 2015; 1 (1): 28–40.
  18. Chelpachenko O. E., Danilova E. I., CHajnikova I.N., Perunova N. B., Ivanova E. I. Bioplenki kishechnyh mikrosimbiontov detej s reaktivnym artritom [Biofi lms of intestinal microsymbionts in children with reactive arthritis] Lechashchij vrach. 2018, no. 4, pp. 56–58
  19. Makarova S. G., Broeva M. I. Different Factors Influencing Early Stages of Intestine Microbiota Formation. Pediatric pharmacology. 2016, vol. 13, no. 3, pp. 270–282. (In Russ.) https://doi.org/10.15690/pf.v13i3.1577
  20. Nikolaeva I. V., Tsaregorodtsev A. D., Shaikhieva G. S. Formation of the intestinal microbiota if children and the factors that infl uence this process. Ros Vestn Perinatol i Pediatr 2018; vol. 63, no. 3, pp. 13–18 (in Russ). DOI: 10.21508/1027–4065–2018–63–3–13–18
  21. Boulange C. L., Neves A. L., Chilloux J., Nicholson J. K, Dumas M. Impact of the gut microbiota on infl ammation, obesity, and metabolic disease. Genome Medicine 2016; 8 (42): 1–12. DOI: 10.1186/sl3073–016–0303–2.
  22. Cardwell C. R., Stene L. C., Joner G. et al. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia. 2008. № 51: 726–735.
  23. Jose P. A., Raj D. Gut microbiota in hypertension. Curr Opin Nephrol Hypertens 2015; 24 (5): 403–409.
  24. Symposium “Destruction of microbioma and functional pathology of the digestive tract in children: acute issues of daily practice”. Review of speeches by I. N. Zakharova, A. I. Khavkin, S. V. Belmer. Pediatrics (Suppl. Consilium Medicum). 2017, no. 4, pp. 59–66.
  25. Szajewska H., Gyrczuk Е., Horvath А. Lactobacillus reuteri DSM 17938 for the Management of Infantile Colic in Breastfed Infants: A Randomized, Double-Blind, Placebo-Controlled Trial. J. Pediatr. 2012; 162: 257–262.
  26. Hunter C, Dimaguila M, Gal P et al. Eff ect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight 1000 grams: a sequential analysis. BMC Pediatr. 2012; 12 (1): 142.
  27. Chicherin I. Yu., Pogorelsky I. P., Lundovskikh I. A., Darmov I. V., Shabalina M. R., Podvolotsky A. N. Comparative experimental evaluation of the eff ectiveness of modern probiotics, prebiotics, synbiotics and metabiotics for correction of intestinal microbiocenosis in animals with antibiotic-associated dysbiosis. 2016, vol. 131, no. 7, pp. 106–120.
  28. Zakharova I. N., Lavrov T. E., Talysina M. F., Machneva E. B. A new look at prebiotics: hypotheses, trends, evidence. Pediatrics (Suppl. Consilium Medicum). 2017, no. 3, pp. 26–33.
  29. Boyle R. J. Tang M. L., Chiang W. C. et al. Prebiotic-supplemented partially hydrolysed cows milk formula for the prevention of eczema in high-risk infants: a randomized controlled trial. Allergy. 2016. 71 (5): 701–710.
  30. Metabiotiki novaya ideya ili estestvennoe razvitie probioticheskoj koncepcii obzor [Metabiotics new idea or natural development of a probiotic concept review] RMJ Medicinskoe obozrenie Gastroehnterologiya. 2017, no. 2, pp. 106–110.
  31. Plotnikova E. Yu., Zakharova Yu. V. Th e place of probiotics in modern clinical practice. Pediatrics (Suppl. Consilium Medicum). 2018; no. 1, pp. 95–99. DOI: 10.26442/2413–8460_2018.1.95–99.
  32. Kang D. W., Adams J. В., Gregory A. C., Borody Т., Chittick L., Fasano A. et al. Microbiota Transfer Th erapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017; 5 (1): 10. DOI: 10.1186/ S40168–016–0225–7
  33. Zaprudnov A. M., Haritonova L. A., Grigorev K. I., Bogomaz L. V. Gastroehnterologiya istoki i perspektivy izucheniya [Problems and perspectives of modern pediatric gastroenterology] Experimental and Clinical Gastroenterology Journal. 2015, no.1, pp. 4–12.
  34. Pahomovskaya N. L., Venediktova M. M. Vliyanie mikrobioty rebenka pervogo goda zhizni na ego razvitie [Impact of early-life microbiota on the development of infants] Medicinskij sovet. 2018, no.2, pp. 200–205.
  35. Hov J.E.R., Tröseid M. Personalised medicine targening the gut microbiiota? Tidssk Den Norlegeforening. 2015; 135 (7): 624–625.

Full text is published :
Kharitonova L. A., Grigoriev K. I., Borzakova S. N. Human microbiote: how a new scientifi c paradigm changes medical practice. Experimental and Clinical Gastroenterology. 2019;161(1): 55–63. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-55-63
Read & Download full text

1. Federal State Budgetary Educational Institution of Higher Education Kuban State Medical University of the Ministry of Health of the Russian Federation, Krasnodar 350001, Russia

Keywords: ecology, children and teenagers from Krasnodar region

Abstract:The aim of the research is to study the infl uence of diff erent pollution levels on clinical and epidemiologic aspects in erosive ulcerous diseases of gastric mucosa and duodenum in children and teenagers. Materials and methods: the research is carried out in Krasnodar region and it consists of two stages. At fi rst stage 47 territories of Krasnodar region are ecologically assessed, at second stage epidemiologic rate (prevalence and sickness rate) of erosive ulcerous diseases of gastric mucosa and duodenum in children and teenagers in Krasnodar region are studied according to data regarding visits to the health care centers and calls of the special medical crews against the ecological condition of the territory. Results. Ecological state of the territories in Krasnodar region diff ers as per anthropogenic load intensity. Low levels of pollution are indicative for regions with favorable ecology (15 regions), medium levels — for regions with conditional favorable ecology (17 regions), and high levels of pollution — for regions with unfavorable ecology (15 regions). There is a numeric dependency between number of children and teenagers visiting health care centers and the level of anthropogenic pollution of regions where they live. The number of children visiting health care centers in connection with erosive ulcerous diseases of gastric mucosa and duodenum is 2.3 times higher, of teenagers — 1.5 times higher against number of patients from regions with favorable ecology.

• References total 10 ⇓ :: .
  1. TSvetkova P.M., Gureev A. N., TSvetkova L.N., et al. Th e modern course of peptic ulcer in children. PEDIATRIA. 2008; 87 (6):31–33. (in Russ)
  2. Vasilieva T. G., Burmistrova T. I., Shishatskaya S. N. Rasprostranennost’ zabolevaniy organov pishchevareniya u detey i podrostkov Primorskogo kraya. Aktual’nyye problemy abdominal’noy patologii u detey: materialy XVIII Kongressa detskikh gastroenterologov Rossii i stran SNG. [Th e prevalence of diseases of the digestive system in children and adolescents of Primorsky Krai // Actual problems of abdominal pathology in children: materials of the XVIII Congress of Pediatric Gastroenterologists in Russia and the CIS]. Moscow, 2011, pp. 12–13. (in Russ)
  3. Panova I. V., Dudnikova E. V., Dombajan S. H. Endocrine status of boys and girls with chronic infl ammatory pathology of upper parts of alimentary tract in the period of puberty. Fundamental research. 2012, no № 12 (part 1), pp. 117–120. (in Russ)
  4. Kildiyarova R. R., Bazhenov E. L. Clinical and morphological comparisons of chronic gastritis, gastroduodenitis and peptic ulcer disease in children. Russian Pediatric Journal. (in Russ)
  5. Tsallagova R. B., Boraeva T. T., Khubaeva I. V. Struktura zabolevayemosti gastroenterologicheskoy patologiyey u detey po dannym detskoy Respublikanskoy klinicheskoy bol’nitsy. [Th e structure of the incidence of gastroenterological pathology in children according to the data of the Children’s Republican Clinical Hospital]. Detskoye zdravookhraneniye Rossii: strategiya razvitiya: materialy IX s’yezda pediatrov Rossii. [Child health care in Russia: development strategy: materials of the IX Congress of Pediatricians of Russia]. Moscow, 2001, 619 p.
  6. TSukanov V.V., Sokolskih T. V., Manchuk V. T., et al. Clinical and morphological characteristics of gastroduodenal zone diseases in families of children. PEDIATRIA. 2008; 87 (6):37–41. (in Russ)
  7. Doklad o sostoyanii okruzhayushchey prirodnoy sredy Krasnodarskogo kraya v 2011 godu. [Report on the state of the environment of the Krasnodar Territory in 2011]. Gosudarstvennyy komitet po okhrane okruzhayushchey sredy Krasnodarskogo kraya. [State Committee for Environmental Protection of the Krasnodar Territory]. Krasnodar. 2011, 170 p. (in Russ)
  8. Doklad o sostoyanii okruzhayushchey prirodnoy sredy Krasnodarskogo kraya v 2017 godu. [Report on the state of the environment of the Krasnodar Territory in 2017]. Gosudarstvennyy komitet po okhrane okruzhayushchey sredy Krasnodarskogo kraya. [State Committee for Environmental Protection of the Krasnodar Territory]. Krasnodar. 2017, 152 p. (in Russ)
  9. Shashel V. A., Nefedov P. V., Nastenko V. P. Sposob otsenki ekologicheskogo sostoyaniya okruzhayushchey sredy. [Th e method of assessing the ecological state of the environment]. Patent 2156975 G 01 № 33/00, Publ. 27.09.2000, no. 27.
  10. Krzyzanowski M. Environment and health of children in Europe // 4th Europaediatries. – M., 2009. – P. 37.

Full text is published :
Shashel V. A., Firsova V. N. Epidemiology of erosive and ulcer diseases of the stomach and duodenum in children and adolescents of Krasnodar Region. Experimental and Clinical Gastroenterology. 2019;161(1): 64–69. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-64-69
Read & Download full text

1. Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia
2. Sechenov First Moscow State Medical University, Moscow, Russia
3. Children’s City Clinical Hospital № 9 named. G. N. Speransky, Moscow, Russia

Keywords: children, cholelithiasis, overweight, cytolysis, cholestasis

Abstract:The purpose of the study was to reveal the frequency and characteristics of the course of the cholelithiasis on the basis of studying the histories of children hospitalized in the Department of Gastroenterology of the State Children’s Hospital No. 9 named after GN Speransky in 2016–2017. Materials and methods: 3200 case histories of children were analyzed; in 32 children, cholelithiasis was diagnosed, among them 11 boys and 21 girls aged 1–9 months to 17 years 8 months. Anthropometric data, family history, duration of the disease, presence of abdominalgia, episodes of a sharp decrease in body weight were evaluated. Laboratory and instrumental studies were conducted. Results: cholelithiasis occurs in 10% of children with digestive tract diseases, mostly in girls, about half of patients had normal body weight and heredity of cholelithiasis, and in every fi fth child, relatives suff ered from excessive body weight. In 28% of cases, cytolysis syndrome (> 10 norms) and cholestasis (> 3 norms) were detected, clinical symptoms of cholelithiasis were noted within 3 months, in half of the children developmental abnormalities and a suspension in the gallbladder cavity were diagnosed. 25% of adolescent girls deliberately reduced body weight. Conclusion: when detecting stones in the gallbladder, it is necessary to determine the indicators of liver and pancreas function, despite the possible absence of complaints of pain in the right hypochondrium.

• References total 09 ⇓ :: .
  1. Ilchenko A. A. Diseases of the gallbladder and biliary tract: A Guide for Physicians., 2nd ed. Moscow, LLC Publishing House Medical Information Agency, 2011, 880 p.
  2. Union of Pediatricians of Russia, clinical guidelines for gallstone disease, 2016
  3. Zaprudnov A. M., Kharitonov L. A. Biliary pathology in children. Moscow, Medical Information Agency. Publ, 2008, 376
  4. Pediatrics: national leadership in 2 tons. Moscow: GEOTAR-Media Publ., 2009, vol. 1, pp. 816–822.
  5. L. A. Haritonova, A. M. Zaprudnov. Diseases of the biliary tract in children – a modern approach to the problem. Pediatria. 2016; 95 (6): 130–139.
  6. Mazurin A. V., Vorontsov I. M. Propedeutics of childhood diseases. Moscow, Medicine Publ., 1986, 430 p.
  7. Volodin N. N., Mukhina Yu. G. Children’s diseases. Vol.2. Gastroenterology. Moscow, Dynasty Publ., 2011, 156–173
  8. Tepaev R. F., Obedin A. N. PAIN SYNDROME IN CHILDREN: DIAGNOSTICS AND TREATMENT (WITH COMMENTARY BY R.F. TEPAEV). Pediatric pharmacology. 2014;11(6):86–91. (In Russ.) https://doi. org/10.15690/pf.v11i6.1222
  9. Davidenko N. V. Kliniko-funktsional’naya kharakteristika, iskhody i prognoz ostrykh pankreatitov razlichnoy etiologii u detey: diss. kand. med. nauk [Clinical and functional characteristics, outcomes and prognosis of acute pancreatitis of various etiologies in children. diss. Cand. med. Sciences]. Moscow, 2006, 176 p.

Full text is published :
Dubrovskaya M. I., Lyalikova V. B., Romanova E. A., Davidenko N. V., et al. Cholelithiasis in the structure of nosology at the pediatric department of children’s city clinical hospital. Experimental and Clinical Gastroenterology. 2019;161(1): 70–74. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-70-74
Read & Download full text

1. Moscow Regional Research and Clinical Institute, Moscow 129110, Russia

Keywords: metabolic syndrome, obesity, children, pancreas, postprandial reaction, thyroid, carbohydrate metabolism, lipid metabolism, fatty liver disease

Abstract:Relevance. Pancreas refers to the organs, the functional state of which is the most signifi cant factor in the development of hormonal and metabolic disorders. Objective: to study the morphofunctional state of the pancreas in children with obesity and to evaluate its relationship with the main components of the metabolic syndrome (MS). Materials and methods. Surveyed 483 children with obesity from 6 to 16 years. Group I — 237 children with obesity complicated by MS, Group II — 246 children with obesity without signs of MS. A complex of clinical, laboratory and instrumental methods of examination was carried out using standard methods; 90 children (60 children from group I and 30 children from group II) underwent an ultrasound examination of the pancreas (RV) with the determination of the postprandial reaction. The results of the study. In 94.9% of children I gr. and 89.8% of children II g. various changes in the structure of the pancreas were revealed: an increase in acoustic density (77.6% and 63.8%, respectively), the presence of hyperechoic inclusions in the parenchyma (86.1% and 82.1%, respectively). The total size of the pancreas on an empty stomach in children in I group exceeded the normative fi gures and was more than that of II gr. (59.85 ± 6.27 mm and 53.11 ± 7.62 mm, respectively, p <0.05). After food stimulation, this indicator amounted to 65.75 ± 7.41 mm in I gr., and about 59.64 ± 5.40mm (p <0.05) in II gr. Exclusively in I gr. (16.7%) postprandial reaction was absent or was sharply reduced (less than 5%). The level of glucose, insulin, C-peptide and HOMA-IR index was higher than in the compared subgroups, and signifi cantly exceeded the standard indicators in children with a reduced postprandial reaction. Triglyceride levels were also signifi cantly higher, and high-density lipoproteins were lower than in other subgroups. In children with non-alcoholic fatty liver disease, the total size of the pancreas on an empty stomach was larger than in children with a normal organ structure (p <0.001), and the postprandial reaction of the pancreas was signifi cantly lower: 7.5% (6.8–8.5%), respectively and 10.4% (11.8–17.9%) (p <0.01). With an increase in the thyroid gland, the size of the pancreas head on an empty stomach was signifi cantly larger than in children with a normal thyroid volume. A decrease in the postprandial response of less than 5% was observed in 33.3% of children with an enlarged thyroid, and in 16.7% of children with normal thyroid size (p <0.05), the normal response of the pancreas (more than 15%) was determined solely in children with not Thyroid gland (11.9%). Findings. Most obese children (up to 95%), regardless of the presence of MS, revealed structural and functional changes in the pancreas. A signifi cant decrease in the postprandial pancreatic response was recorded in children with MS. Only in children with MS (16.7%), the postprandial pancreatic reaction was absent or was sharply reduced (less than 5%), which should be considered as a clinical sign of impaired adaptive capacity of the pancreas against the background of a latent chronic infl ammatory process. The relationship between carbohydrate metabolism and lipid metabolism with the total size and size of the pancreatic head on an empty stomach and after food load has been established. Children with NAFLD have a higher risk of developing CP. A close relationship between the morphofunctional state of the pancreas and thyroids has been established.

• References total 14 ⇓ :: .
  1. Lazebnik LB, Zvenigorodskaya LA. Metabolicheskii sindrom i organi pishevarenia. – М. 2009,181p
  2. Bokova TA. Hepatobiliary system function in children with metabolic syndrome. Experimental and Clinical Gastroenterology Journal. 2016;125(1):14–20.
  3. Ivashkin VT, Shifrin OS, Sokolina IA. Steatos podjeludochnoi jelezi I ego klinicheskoe znachenie. rossiiskii jurnal gastroenterologii, gepatologii, koloproktologii. 2006;16 (4):32–7.
  4. Kucheryavy YA, Moskaleva AB. Vzaimosvyaz hronicheskogo pankreatita s jirovoy bolezniy pecheni I narusheniami uglevodnogo obmena y patientov s ojireniem. Eff ektivnaya farmakoterapia v gastroenterologii. 2011;2:44–9.
  5. Lohr J.-M. Exocrine pancreatic insuffi ciency. – 2-end edition – Bremen: UNI–MED. 2010: 91 p.
  6. Martinez J, Johnson CD, Sanchezрaya J., et al. Obesity is a defi nitive risk factor of severity and mortality in acute pancreatitis: an updatedmetaanalysis. Pancreatology. 2006;17(3):2069.
  7. Maev IV, Kazylin AN, Kucheryavy YA. Hronicheskiy pankreatit. М.: Medicina, 2005. – 504 p.
  8. Barishnikova OV. K voprosu lechenia bolnih hronicheskim pankreatitom s sopytstvyyshim gipotireozom. Vrach-aspirant. 2012;2(51):88–92
  9. Textbook of endocrine physiology. edited by Griffi n J., Ojeda S. M: Binom. 2008: 496 p.
  10. Bokova TA, Ursova NI, Rimarchuk GV, Lebedeva AV. Morphofunctional condition of the pancreas in children and teenagers with obesity and metabolic syndrome. Eksp Klin Gastroenterol. 2008;(7):24–8.
  11. Novikova VP, Usienko EA, Aleshina EI. Sostoyanie podjelydochnoy jelezi pri metabolicheskom syndrome y detei. Lechashiy vrach. 2011;7:71–3
  12. IDF (International Diabetes Federation). Th e IDF consensus defi nition of the metabolic syndrome in children and adolescents. Brussels: IDF, 2007. 24 p.
  13. Cuartero BG, Lacalle CG, Lobo CJ, Vergaz AG. et al. Th e HOMA and QUICKI indexes and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children. An. Pediatr. (Barc.). 2007;66 (5):481–90.
  14. Skude G., Errikson S. Serum isoamylases in chronic pancreatitis. Scand. J. Gastroenterology. – 1976;8:402–7.

Full text is published :
Bokova T. A.Relationship of functional state of pancreas and metabolic syndrome in children. Experimental and Clinical Gastroenterology. 2019;161(1): 75–80. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-75-80
Read & Download full text

1. Northern State Medical University (NSMU), Arkhangelsk 163000, Russia

Keywords: oxidative stress, blood antioxidant ability, metabolic active obesity, metabolic healthy obesity, metabolic syndrome, atherogenic disorders, chronic infl ammation, children, adolescents, schoolchildren

Abstract:The purpose of the study is to assess the level of oxidative stress and impaired blood antioxidant capacity in children and adolescents with metabolic active obesity and other components of the metabolic syndrome. Materials and methods. Surveyed 102 children and adolescents aged 10 to 15 years with obesity. According to the results of clinical and laboratory examinations, groups were identifi ed depending on the presence of metabolic disorders: metabolic active obesity (MAO) and metabolically healthy obesity (MHO). The comparison group consisted of 230 schoolchildren of secondary educational institutions of the city of Arkhangelsk. Results. When comparing groups with MAO, MHO and children without metabolic disorders, it was found that the highest average level of total peroxide (PPS) is observed in the group with MAO, the lowest in the comparison group (<0.001). Among the average indicators of the general antioxidant system (GAS), on the contrary, the lowest value is observed in the group with MAO, the highest — in the comparison group, in children and adolescents with MLO — intermediate values of AOS. The average levels of the studied parameters of proatherogenic metabolic disorders (uric acid (UA), lipid spectrum, glucose, C — reactive protein, blood pressure, HOMA index, insulin) were signifi cantly higher in the group with MAO, except for the average level of high density lipoprotein cholesterol (HDL cholesterol), which is signifi cantly lower. Conclusion. In children and adolescents with MAO, changes in the classic indicators of atherogenic disorders (blood lipid spectrum, blood pressure, insulin resistance, hyperinsulinemia, chronic infl ammation) and high levels of oxidative stress are found, along with a decrease in the activity of the antioxidant system, which may have not only pathogenetic signifi cance, but also reveals promising areas for the prevention and treatment of atherogenic disorders.

• References total 25 ⇓ :: .
  1. Bertuccio P, Levi F, Lucchini F et al. Coronary heart disease and cerebrovascular disease mortality in young adults: recent trends in Europe. European Journal of Cardiovascular Prevention & Rehabilitation August. 2011;18:627–4.
  2. Kardiovaskulyarnaya profi laktika. Natsional’nye rekomendatsii. [Cardiovascular prevention. Th e national recommendations] Kardiovaskulyarnaya terapiya i profi laktika [Cardiovascular therapy and prevention]. 2011;10(6), prilozhenie 2:1–64 (in Russian).
  3. McCrindle BW, Urbina EM, Dennison BA et al. Scientifi c Statement From the American Heart. Association Atherosclerosis, Hypertension and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing. Circulation. 2007;115:1948–67.
  4. Profi laktika serdechno-sosudistykh zabolevaniy v detskom i podrostkovom vozraste. Rossiyskie rekomendatsii. [Prevention of cardiovascular disease in childhood and adolescence. Russian recommendations] Rossiyskiy kardiologicheskiy zhurnal [Russian cardiology journal]. 2012;6(98), prilozhenie 1:1–40 (in Russian).
  5. Hu G, Oiao O, Tuomilehto J. Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women. Arch Intern Med. 2004;164:1066–76.
  6. Problemy gipoksii: molekulyarnye, fiziologicheskie i medicinskie aspekty. [Problems of hypoxia: molecular, physiological and medical aspects]. Pod redakciej L. D. Luk’yanovoj i Ushakova I. B. [Edited by L. D. Lukyanova Ushakova] M 2004, pp 585.
  7. Suhorukov V. S. Ocherki mitohondrial’noj patologii [Study of mitochondrial pathology]. Moscow, Medpraktika-M, 2011. 287 p.
  8. Zimmeta P, Albertib KG, Kaufmanc F et al. Th e metabolic syndrome in children and adolescents – an IDF consensus report. Pediatric Diabetes. 2007;8(5):299–306.
  9. Chumakova GA, Veselovskaya NG, Gritsenko OV i dr. Metabolicheskiy sindrom: slozhnye i nereshennye problemy [Metabolic syndrome: a challenging and unsolved problems]. Rossiyskiy kardiologicheskiy zhurnal [Russian cardiology journal]. 2014;3(107):63–71. (in Russian).
  10. Malyavskaya S. I., Lebedev A. V. Metabolicheskij portret detej s ozhireniem [Metabolic profi le of children with obesity]. Rossijskij vestnik perinatologii i pediatrii [Russian journal of Perinatology and Pediatrics]. 2015, no 6 (60), pp 73–81.
  11. Rosen E. D., Spiegelman B. M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444: 7121: 847–853.
  12. Kelley D. E., Leland T. F., Troost F. et al. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000; 278: 5: E941- E948.
  13. Rosito G. A., Massaro J. M., Hoff mann U. et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcifi cation in a community-based sample: the Framingham Heart Study. Circulation 2008; 117: 5: 605–613.
  14. Succurro E., Marini M. A., Frontoni S. et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity 2008; 16: 1881–1886.
  15. Rishi P. Is it Finally Time to Dispel the Concept of Metabolically-Healthy Obesity? Journal of the American College of Cardiology. 2014;63(24):2687–88.
  16. Gusova ZR, Dzantieva EO, Khripun IA. Immunologicheskie aspekty ozhireniya [Immunological aspects of obesity]. Al’manakh klinicheskoy meditsiny [Almanac of clinical medicine]. 2015; spetsvypusk 1:30–5 (in Russian).
  17. Shaharyar S, Roberson LL, Jamal O et al. Obesity and metabolic phenotypes [metabolically healthy and unhealthy variants] are signifi cantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy Brazilian population. J Obes. 2015;2015:178526.
  18. Takahashi S., Moriwaki Y., Tsutsumi Z. et al. Increased visceral fat accomulation further aggravates the risk of insulin resistance in gout. Metabolism 2001; Apr. 50(4): 393–398.
  19. Nieto F. J., Iribarren С., Gross M. D., Comstock G. W. Uric acid and serum antioxidant capacity: а reaction to atherosclerosis. Atherosclerosis 2000; Vol. 148 (1): 131–139.
  20. Agudelo C. A., Wise C. M. Gout: diagnosis, pathogenesis, and clinical manifestations. Curr Opin Rheumatol 2001; Vol. 13, № 3: 234–239.
  21. Niskanen L. K., Laaksonen D. E., Nyyssonen K. et al. Uric acid level as a risk factor for cardiovascular and all–cause mortality in middle–aged men: a prospective cohort study. Arch Intern Med 2004; Vol. 164: 1546.
  22. Ames B. N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant – and radical–caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858–6862.
  23. Barskova V. G., Il’inyh E.V., Eliseev M. S., Zilov A. V., Nasonov E. L. Kardiovaskulyarnyj risk u bol’nyh podagroj [Cardiovascular risk in patients with gout]. Ozhirenie i metabolizm [Obesity and metabolism]. 2006, no 3(8), pp 40–44.
  24. Lebedev A. V., Malyavskaya S. I., Ternovskaya V. A. Rol’ giperurikemii v koncepcii oksidativnogo stressa pri metabolicheskom sindrome u detej. Novyj vzglyad na staruyu problemu [he Role of hyperuricemia in the concept of oxidative stress in children. A new look at the old problem]. Rossijskij vestnik perinatologii i pediatrii [Russian journal of Perinatology and Pediatrics]. 2012, no. 4 (2), pp 99–104.
  25. Cole TJ, Bellizzi MC, Flegal KM et al. Establishing a standard defi nition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240.

Full text is published :
Malyavskaya S. I., Lebedev A. V., Kostrova G. N. Oxidative stress level and blood antioxidant ability violation in children and adolescents with metabolic syndrome. Experimental and Clinical Gastroenterology. 2019;161(1): 81–87. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-81-87
Read & Download full text

1. Pirogov Russian National Research Medical University (RNRMU), Moscow 117997, Russia
2. City Clinical Hospital No 29 Named after N. E. Bauman, Moscow 111020, Russia

Keywords: diabetes, pregnancy, newborns, physical development

Abstract:Introduction: Every year, 50–150 thousand babies are born to mothers with diabetes. Currently, there is no doubt that the condition of newborns born in mothers with diabetes requires special attention because of the increased risk of developing diseases of the respiratory tract, cardiovascular system, brain, kidneys etc. Purpose: Evaluation of various types of diabetes during pregnancy in mothers infl uence at the physical development of newborn children. Materials and methods: 350 full-term babies from mothers with diabetes mellitus, which was born at the N. E. Bauman Hospital which is specialized in the management of such pregnant women. Assessment of the physical development of children was carried out according to WHO standards (2006) using the WHO Anthro program. Comparative analysis of indicators of children in diff erent groups using Student t-criterion. We used the program Statistica 10. Results: The body mass of 350 examined newborns varied within 1590–4710 g, on average, amounted to 3421.1 ± 543.99 g. There were 67 (19.1%) children who had a body weight less than 3000g and 46 (13.1%) more than 4000 g. Growth values of 350 newborns ranged from 40–57 cm, on average, amounted to 51.21 ± 2.54 cm. We analyzed the indicators of physical development of children in all groups depending on gender. We carried out a comparative analysis of the parameters of body mass (m), body length (H), BMI and the ratio of body mass to body length in the experimental and control groups. Conclusion: children born to mothers with various types of diabetes have a higher height, weight to body length ratio, WAZ and HAZ indicators than newborns from mothers with normal glycemia. The weight and height of newborns in the groups of GDM and DM-2 did not diff er signifi cantly among themselves. The shortest and most lightweight children are born to mothers with type 1 diabetes,

• References total 56 ⇓ :: .
  1. Aulamazyan E. K., Evsyukova I. I., Yarmolinskaya M.l. Th e role of melatonin in development of gestational diabetes mellitus. Journal of Obstetrics and Women’s Diseases. 2017; 67(1): 85–91.
  2. Burumkulova F. F., Petrukhin V. A. Gestacionnyj saharnyj diabet: vchera, segodnya, zavtra: obzor [Gestational diabetes mellitus: yesterday, today, tomorrow]. Terapevticheskij arhiv – [Th erapeutic archive], 2014, V. 86, no. 10, pp. 109–115.
  3. Pakin V. S. Molecular genetic aspects of gestational diabetes. Problems of Endocrinology 2017; 63(3): 204–207
  4. Alharthi A.S., Althobaiti K. A., Alswat K. A. Gestational Diabetes Mellitus Knowledge Assessment among Saudi Women. Open Access Maced J Med Sci. 2018 Aug 19;6(8):1522–1526. doi: 10.3889/oamjms.2018.284.
  5. Domanski G., Lange A. E., Ittermann T., Allenberg H., Spoo R. A., Zygmunt M., Heckmann M. Evaluation of neonatal and maternal morbidity in mothers with gestational diabetes: a population-based study. BMC Pregnancy Childbirth. 2018 Sep 10;18(1):367. doi: 10.1186/ s12884–018–2005–9.
  6. Ferreira A.F., Silva C. M., Antunes D., Sousa F., Lobo A. C., Moura P. Gestational Diabetes Mellitus: Is Th ere an Advantage in Using the Current Diagnostic Criteria? Acta Med Port. 2018 Aug 31;31(7–8):416–424. doi: 10.20344/ amp.10135. Epub 2018 Aug 31.
  7. Hosseini E., Janghorbani M., Shahshahan Z. Comparison of risk factors and pregnancy outcomes of gestational diabetes mellitus diagnosed during early and late pregnancy. Midwifery. 2018 Aug 2;66:64–69. doi: 10.1016/j.midw.2018.07.017.
  8. Goldstein R.F., Abell S. K., Ranasinha S., Misso M. L., Boyle J. A., Harrison C. L., Black M. H., Li N., Hu G., Corrado F., Hegaard H,. Kim Y. J., Haugen M., Song W. O., Kim M. H., Bogaerts A., Devlieger R., Chung J. H., Teede H. J. Gestational weight gain across continents and ethnicity: systematic review and meta-analysis of maternal and infant outcomes in more than one million women. BMC Med. 2018 Aug 31;16(1):153. doi: 10.1186/ s12916–018–1128–1.
  9. Kominiarek M.A., Saade G., Mele L., Bailit J., Reddy U. M., Wapner R. J., Varner M. W., Th orp JM. Jr., Caritis S. N., Prasad M., Tita A. T.N., Sorokin Y., Rouse D. J., Blackwell S. C., Tolosa J. E.; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU). Network Association Between Gestational Weight Gain and Perinatal Outcomes. Obstet Gynecol. 2018 Sep 7. doi: 10.1097/AOG.0000000000002854.
  10. Lekva T., Godang K., Michelsen A. E., Qvigstad E., Normann K. R., Norwitz E. R., Aukrust P., Henriksen T., Bollerslev J., Roland M.CP, Ueland T. Prediction of Gestational Diabetes Mellitus and Pre-diabetes 5 Years Postpartum using 75 g Oral Glucose Tolerance Test at 14–16 Weeks’ Gestation. Sci Rep. 2018 Sep 6;8(1):13392. doi: 10.1038/s41598–018–31614-z.
  11. Saccone G., Khalifeh A., Al-Kouatly H.B., Sendek K., Berghella V. Screening for gestational diabetes mellitus: one step versus two step approach. A meta-analysis of randomized trials. J Matern Fetal Neonatal Med. 2018 Sep 3:1–231. doi: 10.1080/14767058.2018.1519543.
  12. Ridha F., Houssem R., Latifa M., Ines M., Sabra H. Facteurs de risque et pronostic materno-fœtal de la macrosomie fœtale: étude comparative a propos de 820 cas Risk factors and materno-fetal prognosis of foetal macrosomia: comparative study of 820 cases. Pan Afr Med J. 2017 Oct 10; 28:126. doi: 10.11604/pamj.2017.28.126.8508.
  13. Noushin Ghalandarpoor-Attar S., Borna S., Mojgan Ghalandarpoor-Attar S., Hantoushzadeh S., Khezerdoost S., Ghotbizadeh F. Measuring fetal thymus size: a new method for diabetes screening in pregnancy. J Matern Fetal Neonatal Med. 2018 Aug 28:1–171. doi: 10.1080/14767058.2018.1517309.
  14. Basri N.I., Mahdy Z. A., Ahmad S., Abdul Karim A. K., Shan L. P., Abdul Manaf M. R., Ismail N. A.M. Th e World Health Organization (WHO) versus Th e International Association of Diabetes and Pregnancy Study Group (IADPSG) diagnostic criteria of gestational diabetes mellitus (GDM) and their associated maternal and neonatal outcomes. Horm Mol Biol Clin Investig. 2018 Feb 17;34(1). pii: /j/hmbci.2018.34.issue-1/hmbci-2017–0077/ hmbci-2017–0077.xml. doi: 10.1515/hmbci-2017–0077.
  15. Cristina B., Giovanni G., Matilde R., Michele A., Lorella B., Prato Stefano D., Alessandra B. Pre-pregnancy obesity, gestational diabetes or gestational weight gain: which is the strongest predictor of pregnancy outcomes? Diabetes Res Clin Pract. 2018 Sep 3. pii: S0168–8227(18)30972–0. doi: 10.1016/j.diabres.2018.08.019.
  16. Larkin D. M. Optimizatsiya akusherskikh i perinatal’nykh iskhodov u patsiyentok s gestatsionnym sakharnym diabetom. Dokt, Diss. [Optimization of obstetric and perinatal outcomes in patients with gestational diabetes mellitus. Doct. Diss.]. Yekaterinburg, 2016, 114 p.
  17. Lysenko S. N., Chechneva M. A., Petrukhin V. A., Burumkulova F. F., Ermakova L. B. Ultrasound diagnosis of diabetic fetopathy. Russian Bulletin of Obstetrician-Gynecologist. 2016; 3 (16): 23–30.
  18. Akhmetova E. S., Lareva N. V., Mudrov V. A., et al. Features of pregnancy with gestational diabetes mellitus and prediction of diabetic fetopathy. Journal of Obstetrics and Women’s Diseases. 2017;66(4):14–24.
  19. Deryabina E. C., Yakornova G. V., Pestryaeva L. A., Sandyreva N. D. Premature labor in patients with gestational diabetes mellitus. Russian Bulletin of Obstetrician-Gynecologist. 2017; 3 (17): 27–32.
  20. Pivovarova O., Gögebakan Ö., Sucher S., Groth J., Murahovschi V., Kessler K., Osterhoff M., Rudovich N., Kramer A., Pfeiff er A. F. Regulation of the clock gene expression in human adipose tissue by weight loss. Int J Obes (Lond). 2016 Jun; 40(6): 899–906. doi: 10.1038/ijo.2016.34. Epub 2016 Feb 23.
  21. Lan T., Morgan D. A., Rahmouni K., Sonoda J., Fu X., Burgess S. C., Holland W. L., Kliewer S. A., Mangelsdorf D. J. FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia. Cell Metab. 2017 Nov 7; 26(5):709– 718.e3. doi: 10.1016/j.cmet.2017.09.005.
  22. Stamatouli A.M., Quandt Z., Perdigoto A. L., Clark P. L., Kluger H., Weiss S. A., Gettinger S., Sznol M., Young A., Rushakoff R., Lee J., Bluestone J. A., Anderson M., Herold K. C. Diabetes. Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors. Diabetes. 2018 Aug; 67(8):1471–1480. doi: 10.2337/ dbi18–0002.
  23. Petry C.J., Koulman A., Lu L., Jenkins B., Furse S., Prentice P., Matthews L., Hughes I. A., Acerini C. L., Ong K. K., Dunger D. B. Associations between the maternal circulating lipid profi le in pregnancy and fetal imprinted gene alleles: a cohort study. Reprod Biol Endocrinol. 2018 Aug 29;16(1):82. doi: 10.1186/s12958–018–0399-x.
  24. Simpson S., Smith L., Bowe J. Placental peptides regulating islet adaptation to pregnancy: clinical potential in gestational diabetes mellitus.Curr Opin Pharmacol. 2018 Sep 7;43:59–65. doi: 10.1016/j.coph.2018.08.004.
  25. Nikonova T. V., Vityazeva l. l., Pekareva E. V., Barmina 1.1., Alekseeva YU.V., Shestakova M. V. Th e successful in vitro fertilization in the patient with type 1 diabetes on insulin pump therapy (a case report). Russian Journal of Human Reproduction. 2015; 3(21): 75–80.
  26. Borovik N. V., Potin V. V., Rutenburg E. L. Diabeticheskie mikrososudistye oslozhneniya (retinopatiya i nefropatiya) i beremennost’ [Diabetic microvascular complications (retinopathy and nephropathy) and pregnancy]. Zhurnal akusherstva i zhenskih boleznej – [Journal of obstetrics and women’s diseases], 2013, V. LXII, pp. 75–82.
  27. Bender W., Hirshberg A., Levine L. D. Interpregnancy Body Mass Index Changes: Distribution and Impact on Adverse Pregnancy Outcomes in the Subsequent Pregnancy. Am J Perinatol. 2018 Sep 7. doi: 10.1055/ s-0038–1670634.
  28. Vieira M.C., Begum S., Seed P. T., Badran D., Briley A. L., Gill C., Godfrey K. M., Lawlor D. A., Nelson S. M., Patel N., Sattar N., White S. L., Poston L., Pasupathy D.; UPBEAT Consortium. Gestational diabetes modifi es the association between PlGF in early pregnancy and preeclampsia in women with obesity. Pregnancy Hypertens. 2018 Jul; 13:267–272. doi: 10.1016/j.preghy.2018.07.003.
  29. Huet J., Beucher G., Rod A, Morello R., Dreyfus M. Joint impact of gestational diabetes and obesity on perinatal outcomes. J Gynecol Obstet Hum Reprod. 2018 Aug 25. pii: S2468–7847(18)30217–4. doi: 10.1016/j.jogoh.2018.08.003.
  30. Reichelt A.J., Weinert L. S., Mastella L. S., Gnielka V., Campos M. A., Hirakata V. N., Oppermann M. L.R., Silveiro S. P., Schmidt M. I. Clinical characteristics of women with gestational diabetes – comparison of two cohorts enrolled 20 ears apart in southern Brazil. Sao Paulo Med J. 2017 Jul-Aug;135(4):376–382. doi: 10.1590/1516– 3180.2016.0332190317.
  31. Collins K., Oehmen R., Mehta S. Eff ect of obesity on neonatal hypoglycaemia in mothers with gestational diabetes: A comparative study. Aust. N. Z. J. Obstet Gynaecol. 2017: 13. DOI: 10. 1111/ajo.12717.
  32. Moen G.H., Sommer C., Prasad R. B., Sletner L., Groop L., Qvigstad E., Birkeland K. I. Mechanisms in endocrinology: Epigenetic modifi cations and gestational diabetes: a systematic review of published literature. Eur J Endocrinol. 2017 May; 176(5): R247-R267. doi: 10.1530/ EJE-16–1017.
  33. Abell S.K., De Courten B., Boyle J. A., Teede H. J. Infl ammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus. Int J Mol Sci. 2015 Jun 11; 16 (6): 13442–73. doi: 10.3390/ ijms160613442.
  34. Sureshchandra S., Marshall N. E., Wilson R. M., Barr T., Rais M., Purnell J. Q., Thornburg K. L., Messaoudi I. Infl ammatory Determinants of Pregravid Obesity in Placenta and Peripheral Blood. Front Physiol. 2018 Aug 7;9:1089. doi: 10.3389/fphys.2018.01089.
  35. Miehle K., Stepan H., Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf). 2012 Jan;76(1):2– 11. doi: 10.1111/j.1365–2265.2011.04234.x.
  36. Fasshauer M., Blüher M., Stumvoll M. Adipokines in gestational diabetes. Lancet Diabetes Endocrinol. 2014 Jun;2(6):488–99. doi: 10.1016/S2213–8587(13)70176–1.
  37. Retnakaran R., Ye C., Hanley A. J., Connelly P. W., Sermer M., Zinman B., Hamilton J. K. Eff ect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational diabetes mellitus. CMAJ. 2012 Sep 4; 184(12):1353–60. doi: 10.1503/cmaj.111154.
  38. Korkmazer E., Solak N. Correlation between inflammatory markers and insulin resistance in pregnancy. J Obstet Gynaecol. 2015 Feb;35(2):142–5. doi: 10.3109/01443615.2014.948408.
  39. Herrera E., Ortega-Senovilla H. Lipid metabolism during pregnancy and its implications for fetal growth. Curr Pharm Biotechnol. 2014; 15(1): 24–31.
  40. Yanai S., Tokuhara D., Tachibana D., Saito M., Sakashita Y., Shintaku H., Koyama M. Diabetic pregnancy activates the innate immune response through TLR5 or TLR1/2 on neonatal monocyte. J Reprod Immunol. 2016 Sep;117:17–23. doi: 10.1016/j.jri.2016.06.007.
  41. Shaposhnikova E. V., Vedmed A. A., Batchinina O. V. Th e eff ects of gestational diabetes on pregnancy and the neonate: complication and outcomes in births. Smolensk medical almanac. 2017; 4: 57–60.
  42. Aksenov A. N., Bocharova I. I., Bashakin N. F., Troitskaya M. V., Yakubina A. A., Burumkulova F. F., Guryeva V. M. Specifi c features of early postnatal adaptation and management of neonates born to mothers with gestational diabetes mellitus. Russian Bulletin of Obstetrician-Gynecologist. 2015; 4: 75–80.
  43. Nikitina I. L., Konoplya I. S., Polyanskaya A. A., Liskina A. S., Popova P. V. Characterization of psychological and physical development in children of gestation diabetes pregnancies. Meditsinsky Sovet. 2017; 9: 14–20.
  44. Derraik J.G., Ayyavoo A., Hofman P. L., Biggs J. B., Cutfi eld W. S. Increasing maternal prepregnancy body mass index is associated with reduced insulin sensitivity and increased blood pressure in their children. Clin Endocrinol (Oxf). 2015 Sep;83(3):352–6. doi: 10.1111/cen.12665.
  45. Wang J., Pan L., Liu E., Liu H., Liu J., Wang S., Guo J., Li N., Zhang C., Hu G. Gestational diabetes and off spring’s growth from birth to 6 years old. Int J Obes (Lond).2018 Sep 4.doi: 10.1038/s41366–018–0193-z.
  46. Antikainen L., Jääskeläinen J., Nordman H., Voutilainen R., Huopio H. Prepubertal Children Exposed to Maternal Gestational Diabetes Have Latent Low-Grade Infl ammation. Horm Res Paediatr. 2018 Aug 15:1–7.doi: 10.1159/000491938.
  47. Kawasaki M., Arata N., Miyazaki C., Mori R., Kikuchi T., Ogawa Y., Ota E. Obesity and abnormal glucose tolerance in off spring of diabetic mothers: A systematic review and meta-analysis. PLoS One. 2018 Jan 12; 13(1): e0190676. doi: 10.1371/journal.pone.0190676.
  48. Patro Golab B., Santos S., Voerman E., Lawlor D. A., Jaddoe V. W.V., Gaillard R.; MOCO Study Group Authors. Infl uence of maternal obesity on the association between common pregnancy complications and risk of childhood obesity: an individual participant data meta-analysis. Lancet Child Adolesc Health.2018 Sep 7.pii: S2352– 4642(18)30273–6. doi: 10.1016/S2352–4642(18)30273–6.
  49. Shanina O. M., Mikhalev E. V., Saprina T. V. Hemostasis regulation and metabolic (hormonal, electrolyte) disturbances in term newborns from women with gestational diabetes. Diabetes Mellitus. 2015; 1: 78–86
  50. Bellatore A., Scherzinger A., Stamm E., Martinez M. et al. Fetal ovemutrition and adolescent hepatic fat fraction: the exploring perinatal outcomes in children study. J. Pediatr. 2017 Oct 15. pii: S0022–3476(l7)31169–1. DOI: 10.1016/j.jpeds.2017.09.008.
  51. Li S., Zhu Y., Yeung E., Chavarro J. E., Yuan C., Field A. E., Missmer S. A., Mills J. L., Hu F. B., Zhang C. Off spring risk of obesity in childhood, adolescence and adulthood in relation to gestational diabetes mellitus: a sex-specifi c association. Int J Epidemiol. 2017 Oct 1; 46(5):1533–1541. doi: 10.1093/ije/dyx151.
  52. Nikitin A. G., Potapov V. A., Brovkin, Lavrikova E. Y., Khodyrev D. S., Shamhalova M. Sh., Smetanina S. A., Suplotova A. N., Shestakova M. V., Nosikov V. V., Averyanov A. V. Association of the polymorphisms of the FTO, KCNJ11, SLC30A8 and CDKN2B genes with type 2 diabetes. Molecular Biology. 2015; 1 (49): 119–128.
  53. Lin Z., Wang Y., Zhang B., Jin Z. Association of type 2 diabetes susceptible genes GCKR, SLC30A8, and FTO polymorphisms with gestational diabetes mellitus risk: a meta-analysis. Endocrine. 2018 Aug 8. doi: 10.1007/ s12020–018–1651-z.
  54. Troshina E. A., Pokuseava V. N., Andreeva V. N. Ozhirenie u zhenshchin [Obesity in women] / pod redakciej G. A. Mel’nichenko, N. K. Nikiforovskogo [edited by G. Melnichenko, N. K. Nikiforovsky]. Moscow, Medical information Agency, 2017. 272 p.
  55. Hjort L., Martino D., Grunnet L. G., Naeem H., Maksimovic J., Olsson A. H., Zhang C., Ling C., Olsen S. F., Saff ery R., Vaag A. A. Gestational diabetes and maternal obesity are associated with epigenome-wide methylation changes in children. JCI Insight. 2018 Sep 6; 3(17). pii: 122572. doi: 10.1172/jci.insight.122572.
  56. Haertle L., El Hajj N., Dittrich M., Müller T., Nanda I., Lehnen H., Haaf T. Epigenetic signatures of gestational diabetes mellitus on cord blood methylation. Clin Epigenetics. 2017 Mar 27; 9:28. doi: 10.1186/s13148– 017–0329–3.

Full text is published :
Kharitonova L. A., Papysheva O.V., Bogomaz L. V., Bogomaz D. S. Physical development of newborns born to mothers with diff erent carbohydrate metabolism disorders. Experimental and Clinical Gastroenterology. 2019;161(1): 88–98. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-88-98
Read & Download full text

1. Federal State Budgetary Educational Institution of Higher Education Kuban State Medical University of the Ministry of Health of the Russian Federation, Krasnodar 350001, Russia

Keywords: pancreas, children, treatment

Abstract:Purpose of the study. To study the peculiarities of treatment of children with pancreatic diseases on the background of allergic enteropathy in children in out-patient and polyclinic conditions. Materials and methods: 349 children aged 5–18 years with pancreatic diseases were screened against allergic enteropathy. Clinical, biochemical and instrumental methods of examination of sick children were used. Results. Timely diagnosis and treatment of pancreatic diseases on the background of a gastrointestinal form of food allergy (allergic enterocolitis) leads to a persistent improvement in the clinical state and normalization of biochemical parameters in most children.

• References total 06 ⇓ :: .
  1. Belmer S. V., Gasilina T. V., Kovalenko A. A. Lectures on pediatrics. Gastroenterology. Moscow, Russian State Medical University Publ., 2003, vol. 3, pp. 254–264
  2. Rimarchuk G. V. Modern diagnostics and therapy of chronic pancreatitis in children. Pediatric release. 2008;2:34–42
  3. Rylova N. V. A diagnostic algorithm for pancreatic pathology in children Russian Bulletin of Perinatology and Pediatrics. 2010;55(4):54–57
  4. Poleshchuk L. A. Childhood pancreatitis: Current aspects of etiology, pathogenesis, and diagnosis. Russian Bulletin of Perinatology and Pediatrics. 2010;55(4):58–65.
  5. Tsuman V. G., Rimarchuk G. V. et al. Acute pancreatitis in children (clinic, diagnosis, treatment). Manual for doctors. Moscow, 2001. 40 p.
  6. Safdi M, Bekal PK, Martin S et al. Th e eff ects of oral pancreatic enzymes (creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. Pancreas, 2006, 33: 156–162.

Full text is published :
Shashel V. A., Levin P. V. Management of children with diseases of pancreas, occurring on the background of allergic enteropatia in ambulatory and polyclinical conditions. Experimental and Clinical Gastroenterology. 2019;161(1): 99–102. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-99-102
Read & Download full text

1. North-Western State Medical University named after I.I. Mechnikov, St. Petersburg 191014, Russia

Keywords: caries, celiac disease, bone metabolism indicators

Abstract:The aim of this study was to assess the cariesogenic situation in the oral cavity and bone metabolism in children with celiac disease. It is established that in children with early identifi ed with celiac disease, indicators of a cariogenic situation of the oral cavity and the indicators of bone metabolism signifi cantly better than children with later identifi ed with celiac disease. The violation of bone metabolism and a high risk of caries in children with celiac disease were found, and therefore early diagnosis of the disease and compliance with the diet are necessary. And in the treatment of a dentist, a special role is played by medical examination and preventive measures.

• References total 05 ⇓ :: .
  1. Acar S, Yetkıner AA, Ersın N, Oncag O, Aydogdu S, Arıkan C. Author information Oral fi ndings and salivary parameters in children with celiac disease: a preliminary study.//Med Princ Pract. 2012;21(2):129–33. doi: 10.1159/000331794.
  2. Shteyer E, Berson T, Lachmanovitz O, Hidas A, Wilschanski M, Menachem M, Shachar E, Shapira J, Steinberg D, Moskovitz M. Oral health status and salivary properties in relation to gluten-free diet in children with celiac disease.// J Pediatr Gastroenterol Nutr. 2013 Jul;57(1):49–52. doi: 10.1097/MPG.0b013e31828b3705.
  3. Cheng J, Malahias T, Brar P, Minaya MT, Green PH. Th e association between celiac disease, dental enamel defects, and aphthous ulcers in a United States cohort.// J Clin Gastroenterol. 2010 Mar;44(3):191–4. doi: 10.1097/ MCG.0b013e3181ac9942.
  4. Macho VMP, Coelho AS, Veloso E Silva DM, de Andrade DJC. Oral Manifestations in Pediatric Patients with Coeliac Disease – A Review Article.// Open Dent J. 2017 Oct 24;11:539–545. doi: 10.2174/1874210601711010539
  5. Nieri M, Tofani E, Defraia E, Giuntini V, Franchi L. Enamel defects and aphthous stomatitis in celiac and healthy subjects: Systematic review and meta-analysis of controlled studies.//J Dent. 2017 Oct;65:1–10. doi: 10.1016/j.jdent.2017.07.001.

Full text is published :
Silin A. V., Satygo E. A., Melnikova I. Yu. Bone metabolism condition impact on the development of oral cavity caries in children with celiac disease. Experimental and Clinical Gastroenterology. 2019;161(1): 103–105. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-103-105
Read & Download full text

1. Central State Medical Academy of the Administrative Department of the President of Russia, 121359, Moscow, Russia
2. Central Military Clinical Hospital of National Guard, Moscow region, Balashikha 143915, Russia

Keywords:intestinal microbiocenosis, NAFLD, short-chain fatty acids, rifaximin, psyllium

Abstract:Aim of investigation: to study the content and qualitative profi le of shot-chain fatty acids in feces and blood serum in patients with NAFLD of diff erent stages as indicators of intestinal microbiocenosis status and systemic lipid metabolism, and to evaluate the eff ectiveness of course antibacterial (rifaximin) and prebiotic (psyllium) therapy in the period of 6 months for the correction of gut microbiocenosis disorders. Material and methods: The survey included 115 patients (82 (71,3%) men, 33 (28,7%) women) with NAFLD of diff erent stages (steatosis — 40 people, nonalcoholic steatohepatitis (NASH) of minimal activity — 30 people, NASH of moderate activity — 30 people, liver cirrhosis class A Child-Pugh — 15 people) at the average age of 51,83±8,48 years old. All the patients were examined by research of short-chain fatty acids (SCFA) using gas-liquid chromatographic analysis in various biological substrates (blood serum and feces). According to the management scheme, the patients with NAFLD were divided into 3 groups. The fi rst group of 30 people (on the background of lifestyle modifi cation) received a 6-month intake of psyllium. The second group of 35 people in addition to lifestyle modifi cation received a 7-day course of rifaximin (7 — days/800 mg/d) and psyllium during the period of observation (6 months). The third group of 35 people received standard therapy of NAFLD without pharmacotherapy aimed to correction of gut microbiocenosis disorders. In the course of treatment the frequency and severity of clinical manifestations of intestinal bacterial overgrowth syndrome (SIBO) reduced in patients of groups 1 and 2 (in group 1 the complaints on abdominal pain and fl atulence decreased by 11%, in group 2 — by 37%, the normalization of stool occurred in both groups), SIBO was not detected according to the results of the hydrogen breath test with lactulose, the level of total endotoxin was determined within normal values. Negative dynamics was noted in group 3: the increase in the number of complaints of abdominal pain by 16%, fl atulence and unstable stool — by 10%, the frequency of registration of SIBO increased by 20%, increased level of total endotoxin was detected in 5.7% of patients. Results. The absolute concentration of SCFA in feces in patients with NAFLD (steatosis) is reduced, in patients with NASH of minimal activity, NASH of moderate activity and liver cirrhosis is increased, in the profi le of C2-C4 acids there was the increase in the share of propionic and butyric acids and the decline in the share of acetic acid, the anaerobic index (AI) defl ected in the region of strongly negative values, the total relative content of isoacids increased in all groups of patients, worsening with the severity of the pathological process (at normal Σ(С2-С6)=10.51±2.50 mg/g, С2=0.634±0.004, С3=0.189±0.001, С4=0.176±0.004, АI= –0.576(±0.012), Σ(isoСn)=0.068±0.004). The obtained results indicate marked changes in the qualitative and quantitative composition of the microfl ora, the decrease in the number and activity of obligate microorganisms and the increase in facultative and residual anaerobic bacteria. These changes in the microbial landscape lead to the marked disorders in the intestinal phase of lipid metabolism. The absolute concentration of SCFA in serum in patients with NAFLD (steatosis) is reduced, in patients with NASH of minimal activity, NASH of moderate activity is increased, in the profi le of C2-C4 acids there is the decrease in the share of propionic acid and the increase in the share of butyric acid, most pronounced in steatosis and NASH of minimal activity. In patients with liver cirrhosis, the absolute concentration of SCFA in serum is increased, in the profi le of C2-C4 acids, the share of acetic acid is sharply reduced with an increase in the share of propionic and butyric acids and the total relative content of isoacids. The content of caproic and isocaproic acids is increased in all groups (at normal Σ (C2-C6)=0.195±0.011 mg/g, C2=0.902±0.006, C3=0.071±0.004, C4 = 0.027±0.002, Σ (isoCn)=0.040±0.007, isoC6+C6=0.025±0.004). This fact can be explained by the changes in the functional state of hepatocytes, and, consequently, in the metabolic function of the liver (in particular with respect to lipid metabolism). The clinical effi cacy of therapeutic management with the use of drugs aimed at the relief of the intestinal microfl ora disorders (course of rifaximin (if SIBO is identifi ed) on the background of prolonged ingestion of psyllium) in patients with NAFLD of diff erent stages, is supported by the normalization of the content and profi le of SCFA in various biological substrates. In patients of group 3 there was noted the negative dynamics of estimated parameters SCFA. Thus, the results of the undertaken research of the parameters of SCFA in various biosubstrates indicate the marked changes in the intestinal microbiocenosis and their contribution to the development and enhancement of systemic metabolic processes. The inclusion of means aimed at correcting the microecological status disorders in the complex management of NAFLD is not only eff ective, but also pathogenetically necessary.

• References total 39 ⇓ :: .
  1. Drapkina O. M. Patogenez, lechenie i epidemiologiya NAZhBP – chto novogo? Epidemiologiya NAZhBP v Rossii [Pathogenesis, treatment and epidemiology of NAFLD – what’s new? Epidemiology of NAFLD in Russia] / O. M. Drapkina, V. I. Smirin, V. T. Ivashkin // Rossiyskiy meditsinskiy zhurnal. 2011; 28: 1717–1721 [in Russian].
  2. Lazebnik L.B., Zvenigorodskaya L. A., Nilova T. V., Cherkasheva E. A. Contribution of intestinal microfl ora metabolites in diagnosis of nonalcoholic fatty liver disease. Experimental and Clinical Gastroenterology. 2012; 11: 124–132.
  3. Zvenigorodskaya L. A. Non-Alcoholic Fatty Liver Disease: Evolution of Concepts// Eff ektivnaya farmakoterapiya. 2015; 2: 16–22.
  4. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease // Journal of Hepatology. 2016; 64(6): 1388–1402.
  5. Khullar V. Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease / V. Khullar, A. Dolganiuc, R. J. Firpi // World J Transplant. 2014; 4(2): 81–92.
  6. Byrne C. D. NAFLD: A multisystem disease / C. D. Byrne, G. Targher // Journal of hepatology. 2015; 62(1): 47–64.
  7. Diagnostics and treatment of non-alcoholic fatty liver disease / ed. by V. T. Ivashkin – М., 2015. 38 р.
  8. Drapkina O. M., Ivashkin V. T. Epidemiologic features of non-alcoholic fatty liver disease in Russia (Results of open multicenter prospective observational study DIREG L 01903)) // RJGHC. 2014; 24(4): 32–38.
  9. Kravchuk Y. A. Kliniko-morfologicheskiye osobennosti steatogepatita alkogol’noj i metabolicheskoj etiologii. Diss. …dokt. med. nauk. – S.-Pb. 2016; 286 p.
  10. Arslan N., Sayın O., Tokgöz Y. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease // Journal of Pediatric Endocrinology and Metabolism. 2014; 27(5–6): 479–484.
  11. Paolella G., Mandato C., Pierri L., Poeta M., Di Stasi M., Vajro P. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease // World J Gastroenterol. 2014; 20(42): 15518–15531.
  12. Ardatskaya M. D. Klinicheskoye znacheniye KZhK pri patologiyi zheludochno-kishechnogo trakta. Diss. … dokt.med.nauk. – M., 2003. 299 p.
  13. Zvyagintceva T.D., Chernobay A. I., Gridneva S. V. Kishechnyiy mikrobiom i nealkogolnaya zhirovaya bolezn pecheni: patogeneticheskie vzaimosvyazi i korrektsiya probiotikami // http://health-ua.com/wp-content/uploads/2016/04/44–45.pdf
  14. Beloborodova N. V. Integration of metabolism in man and his microbiome in critical conditions// General Reanimatology. 2012; VIII(4): 42–54.
  15. Babak O. Ya., Kolesnikova Е. V. Th e role of adipokines in liver fi brosis at non-alcoholic fatty disease // Modern Gastroenterology. 2009; 5(49): 5–11.
  16. Tokushige K., Hashimoto E., Kodama K. et al. Serum metabolomic profi le and potential biomarkers for severity of fi brosis in nonalcoholic fatty liver disease // J. Gastroenterol. 2013; 48: 1392–1400.
  17. Ledochowski M., Ledochowski E., Eisenmann A. Hydrogen Breath tests. – Verlag Ledochowski, Innsbruck, 2008. – 59 p.
  18. Loginov V. A. Sindrom izbytochnogo bakterial’nogo rosta u bol’nyh so snizhennoj kislotoproduciruyushchej funkciej zheludka (klinicheskoe znachenie, diagnostika i lechenie). – Diss. …kand.med.nauk. – 2015;126 p.
  19. Peredyeriy V.G., Tkach S. M., Sizenko A. K., Shvets O. V. Clinical implications of hydrogen breath tests in gastroenterological practice // Modern Gastroenterology. 2010; 4: 26–32.
  20. Rusanova E.V., Niyazmatov A. G., Protas I. M. Th e role of endotoxin in development of suppurative-septic diseases and methods of endotoxin level determination in blood // Almanac of Clinical Medicine. 2013; 29: 70–73.
  21. Fedos’ina E. A., Zharkova M. S., Mayevskaya M. V. Bacterial intestinal microfl ora and liver diseases // RJGHC. 2009; 19(6): 73–81.
  22. Kitabatake H., Tanaka N., Fujimori N., Komatsu M., Okubo A., Kakegawa K., Kimura T., Sugiura A., Yamazaki T., Shibata S., Ichikawa Y., Joshita S., Umemura T., Matsumoto A., Koinuma M., Sano K., Aoyama T., Tanaka E. Association between endotoxemia and histological features of nonalcoholic fatty liver disease // World J Gastroenterol. 2017; 23(4): 712–722.
  23. Lazebnik L.B., Zvenigorodskaya L. A., Nilova T. V., Cherkashova E. A. Contribution of intestinal microfl ora metabolites in diagnosis of nonalcoholic fatty liver disease. Experimental and Clinical Gastroenterology Journal. 2012; 11: 124–132.
  24. Kurmangulov A. A. Kliniko-funktcional’naya kharakteristika narushenij microbioty kishechnika u pacientov s metabolicheskim syndromom: vozmozhnosti nemedikamentoznoy korrekcii. Diss. …kand.med.nauk. Tyumen, 2016. 129 p.
  25. Topchiy S. N. Rol’ nizkomolekulyarnikh metabolitov kishechnoy microfl ory v otcenke disbioza, prognoze i lichenii bol’nikh s khirurgicheskimi zabolevaniyami Tolstoy kishki. Diss. …kand.med.nauk. M., 2006. 127 p.
  26. Shevcov V. V. Sostoyaniye microbioty dikhatel’nikh putey I kishechnika г bol’nikh rakom lyegkogo, associirovannogo s KhOBL, I metody eyo korrekcii. Diss. …kand. med.nauk. M., 2017. 172 p.
  27. Chirkin V.I., Lazarev I. A., Ardatskaya M. D. Long-term eff ects of alimentary fi bers agent of psyllium (Mucofalk) in patients with metabolic syndrome // Clinicheskiye perspectivy gastroenterologii, gepatologii. 2012; 1: 34–42.
  28. Ivashkin V.T., Drapkina O. M., Mayev I. V. Non-alcoholic fatty liver disease prevalence among patients outpatient practice of the Russian Federation: DIREG 2 study results. // RJGHC. 2015; 6: 31–41.
  29. Luther J., Garber J. J., Khalili H., Dave M., Bale S. S., Jindal R., Motola D. L., et al. Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability. // Cellular and molecular gastroenterology and hepatology. – 2015; 1 (2): 222–232.
  30. Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientifi c Liver Society and the Russian gastroenterological association / ed. by V. T. Ivashkin // RJGHC. 2016; 2: 24–42.
  31. Bacterial metabolism / ed. By Gunzalus I., Steiner R. M., 1963. 450 p. Метаболизм бактерий. Пер. с англ. / под редакцией И. Гунзалус, Р. Стайнер. М.: Издатинлит., 1963. – 450 с.
  32. Gottschalk G. Bacterial metabolism. М., 1982. 310 p.
  33. Byshevskiy A. Sh., Tersenov О. А. Biokhimiya dlya vracha.
  34. Almeida J., Galhenage S., Yu J., Kurtovic J., Riordan S. M. Gut fl ora and bacterial translocation in chronic liver disease // World J Gastroenterol. 2006;12(10):1493–502.
  35. Blum H.E., Bode J. C., Bode C., Sartor R. B.(eds.) Gut and Liver.// Proceeding of the Falk Symposium 100. Kluwer Academic Publishers, 1998, p.86–7, 180, 332–6.
  36. Clausen M.R., Mortensen P. B., Bendsen F. Serum levels of short chain fatty acids in cirrhosis and hepatic civa. // Hepatology 1991, V.14, p. 1040–5.
  37. Wong J.M., de Souza R., Kendall C. W., Emam A., Jenkins D. J. Colonic health: fermentation and short chain fatty acids // J Clin Gastroenterol. 2006 Mar;40(3):235–43.
  38. Sun M., Wu W., Liu Z., Cong Y. Microbiota metabolite short chain fatty acids, GPCR, and infl ammatory bowel diseases // J Gastroenterol. 2017 Jan;52(1):1–8. doi: 10.1007/s00535–016–1242–9.
  39. Anderson J.W., Allgood L. D., Lawrence A., et al.: Cholesterol-lowering eff ects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials// Am J Clin Nutr. 2000; 7:472–479.

Full text is published :
Ardatskaya M. D., Garushyan G. V., Moysak R. P., Topchiy T. B. Role of short chain fatty acids in evaluation of gut microbiocenosis disorders and their correction in patients with NAFLD of diff erent stages. Experimental and Clinical Gastroenterology. 2019;161(1): 106–116. (In Russ.) DOI: 10.31146/16828658-ecg-161-1-106-116
Read & Download full text

1. Republican Specialized Scientifi c Practice Medical Center of Pediatrics, Tashkent, Uzbekistan
2. Tashkent pediatric medical institute (TashPMI), Tashkent 100140, Uzbekistan

Keywords: food protein-induced enterocolitis syndrome, vitamin D, defi ciency, insuffi ciency

Abstract:Aim of the study. To study the status of 25 hydroxyvitamin D in case of food proteins induced enterocolitis syndrome in young children and to determine the relationship between its level and clinical and laboratory manifestations of the disease. Materials and methods. 72 children with Food Proteins Induced Enterocolitis Syndrome aged from 3 months to 3 years were examined. To confi rm the diagnosis, clinical-anamnestic, paraclinical (general blood analysis, coprology, feces for latent bleeding, total protein), and immunological (IgE total, IgE-specifi c antigen-specifi c method, lymphoquin-producing ability of T-lymphocytes to food allergens) were used. For studying the status of vitamin D in the serum of sick children 25 (OH) D3 was determined. Results. The average values of vitamin D in children with gastrointestinal food allergies had marked diff erences in comparison with the norm. Thus, in children with FPIES, they were 20.0 ± 4.4 ng / ml, at a rate of 45.1 ±8.04 ng / ml. Lower vitamin D values occurred in children with more severe clinical manifestations of the disease and, in part, with association with Ig E. By criteria, vitamin D defi ciency was found in 41.6% of children with FPIES, insuffi ciency in 18% of children, in 29 (40.2%) cases, the rates were within the normal range. Conclusion. Thus, it was founded a decrease in the vitamin D values by 2.25 times in food protein induced enterocolitis syndrome, compared with the norm, which dictates the need for the children with FPIES to make aqueous solutions of vitamin D.

• References total 31 ⇓ :: .
  1. Klyikova T. V., Agafonova E. V., Reshetnikova I. D. Pischevaya allergiya u detey rannego vozrasta: podhodyi k diagnostike i lecheniyu. Prakticheskaya meditsina. 2011; 3 (51) 125–8
  2. Burks AW, Tang M, Sicherer S et al. ICON: food allergy. J AllergyClinImmunol. 2012;129:906–20.
  3. Latcham F., Merino F., Lang A. et al. A consistent pattern of minor immunodefi ciency and subtle enteropathy in children with multiple food allergy // J Pediatr. 2003; 143: 39–47.
  4. Sampson H. A. Update on food allergy. J Allergy ClinImmunol. 2004;113:805–19; quiz 20.
  5. Anderson P. Jones, PG Dip, Debra Palmer, PhD, Guicheng Zhang, PhD, and Susan L. Prescott, MBBS, Ph D. Cord Blood 25-Hydroxy vitamin D3 and Allergic Disease During Infancy Pediatrics 2012;130: e1128–e1135.
  6. D.G Peroni, G.L Piacentini, E Cametti, I Chinellato, AL Boner. Br J Dermatol. Correlation Between Serum 25-Hydroxyvitamin D Levels and Severity of Atopic Dermatitis in Children. 2011;164(5):1078–1082.
  7. Weisse K, Winkler S, Hirche F, et al. Maternal and newborn vitamin D status and its impact on food allergy development in the German LINA cohort study. Allergy.2013;68(2):220–228
  8. Allen KJ, Koplin JJ, Ponsonby AL, et al. Vitamin D Insuffi ciency Is Associated With Challenge-Proven Food Allergy in Infants. JAllergyClinImmunol. 2013;131(4):1109– 1116, e1–e6
  9. Mirzamuhamedov D. M. Diagnosticheskoe znachenie limfotoksina u detey s atopicheskoy bronhialnoy astmoy. Metodicheskie rekomendatsii. Tashkent. 1989
  10. Boyum A. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigen. 4:269–74, 1974
  11. Ruffner M. A., Ruymann K., Barni S., Cianferoni A., Brown-Whitehorn T., Spergel J. M. Food protein-induced enterocolitis syndrome: insights from review of a large referral population. Journal of Allergy and Clinical Immunology: In Practice. 2013;1(4):343–349
  12. Holick MF. VitaminD Deficiency. NEnglJMed 2007;357:266–81.
  13. Baranov A. A., Balabolkin I. I., Subbotina O. A. Gastrointestinalnaya pischevaya allergiya u detey. – M.: Dinastiya, 2002. – P. 172.
  14. Shikha K. Mane and Sami L. Bahna. Clinical manifestations of food protein-induced enterocolitis syndrome. Curr Opin Allergy Clin Immunol 2014, 14:217–221
  15. Sicherer SH, Eigenmann PA, Sampson HA. Clinical features of food protein induced enterocolitis syndrome. J Pediatr. 1998; 133:214–219.
  16. Nowak-Wegrzyn A, Sampson HA, Wood RA, Sicherer SH. Food protein induced enterocolitis syndrome caused by solid food proteins. Pediatrics. 2003; 111:829–835.
  17. Nowak-Wegrzyn A, Muraro A. Food protein-induced enterocolitis syndrome. Curr Opin Allergy Clin Immunol. 2009; 9:371–377
  18. Onesimo R, Dello Iacono I, Giorgio V, et al. Can food protein induced enterocolitis syndrome shift to immediate gastrointestinal hypersensitivity? A report of two cases. Eur Ann Allergy Clin Immunol 2011; 43:61–63
  19. Ichiro Nomura Hideaki Morita, MDd Shinichi Hosokawa, MDf Hiroaki Hoshina, MDg Tatsuki Fukuie, MDa et all Ph D. Four distinct subtypes of non–IgE-mediated gastrointestinal food allergies in neonates and infants, distinguished by their initial symptoms. J Allergy Clin Immunol. March, 2011, 685–688. doi:10.1016/j. jaci.2011.01.019
  20. Beda Muehleisen, MD, and Richard L. Gallo, MD. Vitamin D in allergic disease: Shedding light on a complex problem Allergy ClinImmunol 2013;131:324–9
  21. H. Mirzakhani1,2, A. Al-Garawi1,2, S. T. Weiss1,2,3 and A. A. Litonjua. Vitamin D and the development of allergic disease: how important is it? Clinical & Experimental Allergy, 45, 114–125
  22. Ian Adcock, Yassine Amrani, Adcock I, Amrani Y. Role of Vitamin D Defi ciency in Allergic Diseases: Is this Due to an Impaired Patients’ Response to Corticosteroid Th erapy?. Immunol 2 1–3. 2014
  23. Hypponen E, Sovio U, Wjst M, Patel S, Pekkanen J, Hartikainen AL, et al. Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann N Y AcadSci 2004;1037:84–95
  24. Majak P, Olszowiec-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy ClinImmunol 2011;127:1294–6
  25. Sidbury R, Sullivan AF, Th adhani RI, Camargo CA Jr. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol 2008;159:245–7.
  26. Roider E, Ruzicka T, Schauber J. Vitamin D, the cutaneous barrier, antimicrobial peptides and allergies: is there a link? AllergyAsthImmunolRes 2013; 5:119–28.
  27. Gale CR, Robinson SM, Harvey NC et al. Princess Anne Hospital Study G, Maternal vitamin D status during pregnancy and child outcomes. Eur J ClinNutr 2008; 62:68–77.
  28. Hata TR, Kotol P, Jackson M et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. JAllergyClinImmunol 2008; 122:829–31.
  29. Willits EK, Wang Z, Jin J, Patel B, Motosue M, Bhagia A, Almasri J, Erwin PJ, Kumar S, Joshi AY. Vitamin D and food allergies in children: A systematic review and meta-analysis. Allergy Asthma Proc. 2017 May 1;38(3):21– 28. doi: 10.2500/aap.2017.38.4043.
  30. Zaharova I. N., Gromova O. A., Maykova I. D. i soavt. Chto nuzhno znat pediatru o vitamine D: novyie dannyie o diagnostike i korrektsii ego nedostatochnosti v organizme. Pediatriya, 2015.-N6.-S.151–158
  31. Tsung-Chieh Yao. Suboptimal Vitamin D Status in a Population-Based Study of Asian Children: Prevalence and Relation to Allergic Diseases and Atopy. PLoS One. 2014; 9(6): e99105. 2014 Jun 3. doi: 10.1371/journal. pone.0099105

Full text is published :
Kamilova A. T., Geller S. I., Dustmukhamedova D. Kh., et al. Status of vitamin D in the food protein induced enterocolitis syndrome in children. Experimental and Clinical Gastroenterology. 2019;161(1): 117–123. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-117-123
Read & Download full text

1. St. Petersburg State Pediatric Medical University, St. Petersburg 194044, Russia
2. Yu. E. Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University, Moscow 125412, Russia
3. I. I. Mechnikov North-Western State Medical University, St. Petersburg 195067, Russia
4. D. O. Ott Institute of Obstetrics, Gynecology and Reproduction, St. Petersburg 199034, Russia

Keywords: ghrelin, serotonin, chromogranin A, celiac disease, giardiasis, Нelicobacter pylori.

Abstract:Growth pathology duodenal among patients of diff erent age groups determines the relevance of the study. Causes duodenal disease suffi ciently heterogeneous and include celiac disease, gluten allergy and various proteins, autoimmune disease, atopy, and also bacterial, parasitic and viral infection (Helicobacter pylori infection, giardiasis). One of the characteristics of the mucosal morphofunctional state is its neuroendocrine duodenal activity, which is provided enteroendocrine cells, and chromogranin synthesizing neuropeptides, in particular, chromogranin A (CgA), ghrelin and serotonin. The aim of our study was to determine whether these markers in the duodenal mucosa with similar morphological manifestations duodenitis of various etiologies in children. The material of the study were 40 biopsies of the distal duodenum, obtained by fi brogastroduodenoscopy in children aged 6 to 17 years old with morphologically verifi ed chronic gastroduodenitis (CGD). The fi rst group consisted of children with celiac disease, the second group — with Helicobacter pylori infection (H.p), the third group consisted of children with giardiasis, in the fourth (the control group) — children with reliably excluded above listed diseases and preserved architectonic mucosal duodenum without morphological characters gastroduodenitis.When immunohistochemical study (IHC) expression levels were determined Chromogranin A (Abcam 1: 400); Serotonin (Abcam 1:50); Ghrelin (Abcam 1: 100). The intensity of the reaction was assessed by two indicators — the relative expression area (Ot. Pl) and the optical density (OP). In our study, for the fi rst time we studied markers in enteroendocrine duodenitis of various etiologies. We were looking for a morphological tool that will help diff erentiate duodenitis with similar clinical and histological features. Increased expression of ghrelin, serotonin and chromogranin A, playing an important role in the mechanisms of disorders duodenum structure in celiac disease. When H.p infections a decrease in all studied markers, while giardiasis is not observed signifi cant changes. All of this allows us to diff erentiate duodenitis etiology and, therefore, reasonable to appoint therapeutic measures.

• References total 13 ⇓ :: .
  1. Kentaro S. Kyoto global consensus report on Helicobacter pylori gastritis / S Kentaro, T. Jan, J. K. Ernst, G. David, [et al.] // Guidelines. 2015. 64.Р.1353–1367.
  2. Oberhuber G. Th e histopathology of coeliac disease: time for a standardized report scheme for pathologists / G. Oberhuber, G. Granditsch, H. Vogelsang // Eur J Gastroenterol Hepatol. 1999. 1. Р. 1185–94.
  3. Komisarova M.YU., Novikova V. P., Kalinina Ye.YU., Shats I. A. Kliniko-anamnesticheskiye osobennosti khronicheskogo duodenita u detey. [Clinical and anamnestic features of chronic duodenitis in children]. Voprosy sovremennoy pediatrii – [Questions of modern pediatrics], 2006, vol. 5, no. 1, p. 276.
  4. Volynets G. V., Khavkin A. I., Filatov F. P., Astakhova N. I., Murashkin V.YU., Garanzha T. A., Yaroslavtseva N. G. Zabolevaniya verkhnikh otdelov organov pishchevareniya u detey s khronicheskoy Epshteyna-Barr virusnoy infektsiyey. [Diseases of the upper parts of the digestive organs in children with chronic Epstein-Barr viral infection]. Rossiyskiy pediatricheskiy zhurnal– [Russian Pediatric Journal], 2004, no. 6, pp. 49–51.
  5. Khavkin A. I., Bekhtereva M. K., Luppova N. Ye., Korniyenko Ye.A., Minina S. N., Novikova V. P., Osmalovskaya Ye.A., Privorotskiy V. F., Staroverov YU.I., Tkachenko M. A., Shabalov N. P., Gonchar N. V., Panfi lova V. N., Yamoldinov R. N., Bel’mer S.V., Nizhevich A. A. Rabochiy protokol diagnostiki i lecheniya lyamblioza u detey [Working protocol for the diagnosis and treatment of giardiasis in children]. Voprosy detskoy diyetologii – [Questions of children’s nutrition], 2013, vol.11, no.6, pp. 72–77.
  6. Miller L. Gastrointestinal hormones and receptors. / Textbook of Gastroenterology// Lippincot-Williams and Wilkins, Philadelphia. 2009.Р. 56–85.
  7. Tiago P. Detailed characterization оf incretin cell distribution along the human small intestine / P. Tiago, M. D. Guedes, M. Sofi a // Surgery for Obesity and Related Diseases. 2015. Vol. 12.P.1–9.
  8. Zissimopoulos A. Chromogranin A as a biomarker of disease activity and biologic therapy in infl ammatory bowel disease: a prospective observational study / A. Zissimopoulos, S. Vradelis, M. Konialis, // Scand. J. Gastroenterol. 2014.№ 49. Р. 942–949.
  9. Kalinina Ye.YU., Anichkov N. M., Krylova YU., Novikova V. P. Neyroendokrinnyye diff erony pri duodenitakh razlichnoy etiologii u detey [Neuroendocrine diff erons for duodenitis of various etiologies in children.]. Voprosy detskoy diyetologii – [Questions of children’s nutrition], 2017, vol.15, no.2, pp. 49–50.
  10. Saleem K. Ghrelin and melatonin as biomarkers in patients with giardiasis / K. Saleem, E. Mohammed, M. Malak // Biotechnology & Biotechnological Equipment. 2016. Vol. 30. № 3. Р. 553–557.
  11. Gershon M. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract / M. Gershon // Curr. Opin. Endocrinol. Diabetes Obes. 2013. Vol.20. P. 14–21.
  12. Margaret C. Celiac disease, short stature and growth hormone deficiency / C. Margaret, S. Boguszewski, A. C. Demartini // Gastrointest Cancer. 2015. Vol.4. № 1. Р.69–75.
  13. Boltin D. Ghrelin. Helicobacter pylori and body mass: is there an association? / D. Boltin, Y. Niv // J Isr Med Assoc. 2012. Vol.14. № 2. Р.130–32.

Full text is published :
Novikova V. P., Khavkin A. I., Kalinina E. Yu., Anichkov N. M., Krylova Yu. S. Diagnostic signifi cance of diff erones in chronic duodenites in children. Experimental and Clinical Gastroenterology. 2019;161(1): 124–128. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-124-128
Read & Download full text

1. FDO FGBOU IN “Russian Research Medical University. Pirogov” of Ministry of Health of Russia, Moscow, Russia
2. Federal State Budgetary Educational Institution of Higher Education Kuban State Medical University of the Ministry of Health of the Russian Federation, Krasnodar 350001, Russia

Abstract:The article presents a review of the literature on the etiopathogenesis, diagnosis and treatment of parasitic invasions in children. The etiological structure of parasites infecting the biliary system, their development cycles and places of the most frequent parasitism in the external environment are described. It is convincingly shown that Giardia has nothing to do with the gallbladder and the biliary tract. It is noted that the most frequent pathogens of parasitic invasions of the biliary tract in children are opisthorchiasis, clonorchosis and fascioliasis. The role of parasitic invasions in the formation of gallstones is shown. At the same time, the key pathogenetic mechanisms of stone formation in cholelithiasis on the background of parasitic invasion is the activation of cholesterol and pigment lithogenesis, the deconjugation of direct bilirubin in bile. It is shown that the main in the treatment of parasitic invasions is the use of etiotropic therapy (deworming). Based on a detailed analysis of modern literature, therapeutic tactics algorithms have been developed.

• References total 29 ⇓ :: .
  1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. //A review of human carcinogens// Part B: biological agents. Lancet Oncol. 2009; 10:321–2. [PubMed]
  2. IARC A review of human carcinogens part B: Biological Agents. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2011; 100B:457.
  3. Khamidullin A. R., Saifutdinov R. G., Haertynova I. M. Interregional Clinical Diagnostic Center. Practical medicine. 2011;3–2 (51):35–37.
  4. Sithithaworn P, Andrews RH, Nguyen VD, et al. // Th e current status of opisthorchiasis and clonorchiasis in the Mekong Basin.// Parasitol Int. 2011;61(1):10–6.
  5. Lai YS, Zhou XN, Pan ZH, Utzinger J, Vounatsou P. et al. // Risk mapping of clonorchiasis in the People’s Republic of China: A systematic review and Bayesian geostatistical analysis. //PLoS Negl Trop Dis. 2017;11(3): e0005239. Published 2017 Mar 2. doi:10.1371/journal.pntd.0005239
  6. Ogorodova L., Deev I., Fedorova O., Sazonov A., Petrova I., Eliseeva O., Kamaltynova E., Petrovskaya Y. PREVALENCE OF HELMINTHIASIS OPISTHORCHIS FELINEUS IN CHILDREN IN TOMSK AND TOMSK REGION. Current pediatrics. 2011;10(3):43–47.
  7. Klinicheskiye rekomendatsii (protokol lecheniya) okazaniya meditsinskoy pomoshchi detyam, bol’nym opistorkhozom. [Clinical recommendations (treatment protocol) for the provision of medical care to children with opisthorchiasis]. FSBI NIIDI FMBA of Russia, 2014.
  8. Opistorkhoz u vzroslykh. Klinicheskiye rekomendatsii. [Opisthorchiasis in adults. Clinical guidelines]. Plenum pravleniya Natsional’nogo nauchnogo obshchestva infektsionistov 30.10.2014. [Plenum of the Board of the National Scientifi c Society of Infectiologists on October 30, 2014]
  9. Sergiev V. P., Lobzin Yu.V., Kozlov S. S. Parasitic diseases of man. Publisher “Foliant”, St. Petersburg, 2008.
  10. Concept of the pathogenesis and treatment of cholelithiasis. World J Hepatol. 2012;4(2):18–34. https://www.ncbi. nlm.nih.gov/pmc/articles/PMC3295849/
  11. Vítek L, Carey MC. New pathophysiological concepts underlying pathogenesis of pigment gallstones. Clin Res Hepatol Gastroenterol. 2011;36(2):122–9. https://www. ncbi.nlm.nih.gov/pmc/articles/PMC3311771/
  12. Cholecystolithiasis Is Associated with Clonorchis sinensis Infection / Tie Qiao, Rui-hong Ma, Xiao-bing Luo [et al]// PLoS One. 2012. Vol 7.№ 8.Р. 424–427.
  13. EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. European Association for the Study of the Liver (EASL) // Journal of Hepatology. 2016.Vol. 65, № 1. P. 146–181.
  14. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN / L. J. Wang, C. C. He, X. Sui [et al.] // Oncotarget. 2015. vol. 6. № 8. P. 5932–5946.
  15. Buisson Y. // Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention // Bulletin de la Société de pathologie exotique. 2017. vol. 110. № 1. P. 61–67.
  16. Bychkov V. G., Khadieva E. D., Zuevskiy V. P., et al. Regularities of carcinogenesis against the background of a superinvasive opisthorchiasis. Tyumen Medical Journal. 2015;17(3):11–13.
  17. Baykova O. A., Nikolaeva N. N., Grishchenko E. G., Nikolaeva L. V. Cholangiocarcinoma associated with chronical opisthorchiasis and clonorchiasis. Th e Journal of scientifi c articles “Health and Education Millennium”, 2018, Vol. 20, No 4, pp. 27–32. DOI: http://dx.doi.org/10.26787/ nydha-2226–7425–2018–20–4–27–32
  18. Newsome JR, Venkatramani R, Heczey A, Danysh HE, Fishman DS, Miloh T. // Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis// Journal of Pediatric Gastroenterology and Nutrition. 66(1): e12–e18, JAN2018.
  19. Nobuyuki Saikusa hinichi Naito, Yasushi Iinuma, Tetuya Ohtani, Naoyuki Yokoyama, Kohjyu Nitta. //Invasive cholangiocarcinoma identifi ed in congenital biliary dilatation in a 3-year-old boy// Journal of Pediatric Surgery. November 2009 Volume 44, Issue 11, Pages 2202–2205.
  20. Baykova О. А., Nikolaeva N. N., Grisbcbenko E. G., Nikolaeva L. V. Liver trematode infection – opisthorchiasis and clonorchiasis: actual problems and principles of diagnosis in modern clinical practice (reviewof liтerature) Byulleten’ Vostochno-Sibirskogo nauchnogo tsentra Sibirskogo otdeleniya Rossiyskoy akademii meditsinskikh nauk. – Bulletin of the East-Siberian Scientifi c Center of the Siberian Branch of the Russian Academy of Medical Sciences. 2016, vol.1, no 6(112):182–190.
  21. Baykova O. A., Nikolaeva N. N., Grishchenko E. G., Nikolaeva L. V. Opisthorchiasis and clonorchiasis treatment: modern approach, concerns and perspectives. Th e Journal of scientifi c articles “Health and Education Millennium”, 2018, Vol. 19, No 6, pp. 14–25. DOI: http://dx.doi.org/10.26787/nydha-2226–7425–2017–19–6–14–25
  22. Mordvinov V. A., Pakharukova M. Yu., Katokhin A. V., et al. Siberian Opisthorchosis. Biology, Distribution and Development of New Preparations for Its Treatment. Chemistry for Sustainable Development. 2015;23(5):579–584.
  23. Plotnikova E. Yu., Baranova Е. N. Problems of treatment of opisthorchiasis. RMJ. Medical Review. 2018. № 3. P. 53–56.
  24. Plotnikova E. Yu., Baranova Е. N. Opistorchoz: complications and problems of treatment. Gastroenterologiia Sankt-Peterburga. 2018; (3):14–18.
  25. Bliznets О. I. Clonorchiasis in children in the Upper Amur River Region. Children’s Infections. 2009;8(4):63–64.
  26. Sayasone S1, Odermatt P 2, Vonghachack Y3, Xayavong S1, Senggnam K 1, Duthaler U4, Akkhavong K 1, Hattendorf J 2, Keiser J 5 //Effi cacy and safety of tribendimidine against Opisthorchis viverrini: two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials.//2016, https:// www.ncbi.nlm.nih.gov/pubmed/27472949
  27. El-Karaksy B Hassanein S Okasha B Behairy I Gadallah. // Human fascioliasis in Egyptian children: successful treatment with triclabendazole.// Journal of Tropical Pediatrics, Volume 45, Issue 3, 1 June 1999, Pages 135–138, https://doi.org/10.1093/tropej/45.3.135
  28. Fidel Villegas, René Angles, René Barrientos, Gary Barrios // Effi cacy and tolerability of two single-day regimens of triclabendazole for fascioliasis in Peruvian children. // Administration of Triclabendazole Is Safe and Eff ective in Controlling Fascioliasis in an Endemic Community of the Bolivian Altiplano, Published: August 7, 2012 https:// doi.org/10.1371/journal.pntd.0001720
  29. Metodicheskiye ukazaniya 3.2.2601–10 [Methodical instructions 3.2.2601–10]. Profi laktika opistorkhoza. Utverzhden Federal’noy sluzhboy po nadzoru v sfere zashchity prav potrebiteley i blagopoluchiya cheloveka. [Prevention of opisthorchiasis. Approved by the Federal Service for Supervision of Consumer Rights Protection and Human Welfare]. 2010.

Full text is published :
Kharitonova L. A., Kucherya T. V., Bostanjyan V. R., Veselova E. A., Matalaeva S. Yu. The role of parasitic invasions in the genesis of infl ammatory diseases of biliary tract in children. Experimental and Clinical Gastroenterology. 2019;161(1): 129–136. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-129-136
Read & Download full text

1. Federal State Budgetary Educational Institution of Higher professional Education of the Russian national research medical University n. a N. I. Pirogov, Moscow 117997, Russia
2. N. E. Bauman City Clinical Hospital No 29, Moscow Department of Health, Moscow 111020, Russia

Keywords: gestational diabetes mellitus, insulin resistance, obesity

Abstract:Gestational diabetes mellitus (GDM) develops in 7–18% of women worldwide. The number of pregnant with GDM is steadily increasing. GDM is more likely to develop among obese patients. Women who are obese have features of chronic low-grade infl ammation, manifest by increased tumour necrosis factor alpha (TNF-α), interleukin-6 (IL-6), interleukin-12 (IL-12), and high sensitivity C-reactive protein (hsCRP). Obesity is characterised by insulin resistance, and down-regulation of adiponectin and up-regulation of leptin, resistin and retinol-binding protein-4 (RBP4) contribute to this. Obesity and excess gestational weight gain results in a three-fold increased risk of adverse pregnancy outcomes, including long term metabolic syndrome and endocrine diseases for baby. Off spring born from pregnancies complicated by GDM has higher body mass index (BMI) compared with non-GDM off spring and has high risk of obesity throughout all periods of childhood. GDM may have impact on genetic modifi cations in the off spring.

• References total 52 ⇓ :: .
  1. Aulamazyan E. K., Evsyukova I. I., Yarmolinskaya M.l. Th e role of melatonin in development of gestational diabetes mellitus. Journal of Obstetrics and Women’s Diseases. 2017; 67(1): 85–91 (in Russ).
  2. Burumkulova F. F., Petrukhin V. A. Gestacionnyj saharnyj diabet: vchera, segodnya, zavtra: obzor [Gestational diabetes mellitus: yesterday, today, tomorrow]. Terapevticheskij arhiv – [Th erapeutic archive], 2014, V. 86, no. 10, pp. 109–115 (in Russ).
  3. Pakin V. S. Molecular genetic aspects of gestational diabetes. Problems of Endocrinology 2017; 63(3): 204– 207(in Russ).
  4. Alharthi A.S., Althobaiti K. A., Alswat K. A. Gestational Diabetes Mellitus Knowledge Assessment among Saudi Women. Open Access Maced J Med Sci. 2018 Aug 19;6(8):1522–1526. doi: 10.3889/oamjms.2018.284.
  5. Domanski G., Lange A. E., Ittermann T., Allenberg H., Spoo R. A., Zygmunt M., Heckmann M. Evaluation of neonatal and maternal morbidity in mothers with gestational diabetes: a population-based study. BMC Pregnancy Childbirth. 2018 Sep 10;18(1):367. doi: 10.1186/ s12884–018–2005–9.
  6. Ferreira A.F., Silva C. M., Antunes D., Sousa F., Lobo A. C., Moura P. Gestational Diabetes Mellitus: Is Th ere an Advantage in Using the Current Diagnostic Criteria? Acta Med Port. 2018 Aug 31;31(7–8):416–424. doi: 10.20344/ amp.10135. Epub 2018 Aug 31.
  7. Hosseini E., Janghorbani M., Shahshahan Z. Comparison of risk factors and pregnancy outcomes of gestational diabetes mellitus diagnosed during early and late pregnancy. Midwifery. 2018 Aug 2;66:64–69. doi: 10.1016/j. midw.2018.07.017.
  8. Goldstein R.F., Abell S. K., Ranasinha S., Misso M. L., Boyle J. A., Harrison C. L., Black M. H., Li N., Hu G., Corrado F., Hegaard H,. Kim Y. J., Haugen M., Song W. O., Kim M. H., Bogaerts A., Devlieger R., Chung J. H., Teede H. J. Gestational weight gain across continents and ethnicity: systematic review and meta-analysis of maternal and infant outcomes in more than one million women. BMC Med. 2018 Aug 31;16(1):153. doi: 10.1186/ s12916–018–1128–1.
  9. Kominiarek M.A., Saade G., Mele L., Bailit J., Reddy U. M., Wapner R. J., Varner M. W., Th orp JM. Jr., Caritis S. N., Prasad M., Tita A. T.N., Sorokin Y., Rouse D. J., Blackwell S. C., Tolosa J. E. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU). Network Association Between Gestational Weight Gain and Perinatal Outcomes. Obstet Gynecol. 2018 Sep 7. doi: 10.1097/AOG.0000000000002854.
  10. Lekva T., Godang K., Michelsen A. E., Qvigstad E., Normann K. R., Norwitz E. R., Aukrust P., Henriksen T., Bollerslev J., Roland M.CP, Ueland T. Prediction of Gestational Diabetes Mellitus and Pre-diabetes 5 Years Postpartum using 75 g Oral Glucose Tolerance Test at 14–16 Weeks’ Gestation. Sci Rep. 2018 Sep 6;8(1):13392. doi: 10.1038/s41598–018–31614-z.
  11. Saccone G., Khalifeh A., Al-Kouatly H.B., Sendek K., Berghella V. Screening for gestational diabetes mellitus: one step versus two step approach. A meta-analysis of randomized trials. J Matern Fetal Neonatal Med. 2018 Sep 3:1–231. doi: 10.1080/14767058.2018.1519543.
  12. Ridha F., Houssem R., Latifa M., Ines M., Sabra H. Facteurs de risque et pronostic materno-fœtal de la macrosomie fœtale: étude comparative a propos de 820 cas Risk factors and materno-fetal prognosis of foetal macrosomia: comparative study of 820 cases. Pan Afr Med J. 2017 Oct 10; 28:126. doi: 10.11604/pamj.2017.28.126.8508.
  13. Noushin Ghalandarpoor-Attar S., Borna S., Mojgan Ghalandarpoor-Attar S., Hantoushzadeh S., Khezerdoost S., Ghotbizadeh F. Measuring fetal thymus size: a new method for diabetes screening in pregnancy. J Matern Fetal Neonatal Med. 2018 Aug 28:1–171. doi: 10.1080/14767058.2018.1517309.
  14. Basri N.I., Mahdy Z. A., Ahmad S., Abdul Karim A. K., Shan L. P., Abdul Manaf M. R., Ismail N. A. M. Th e World Health Organization (WHO) versus Th e International Association of Diabetes and Pregnancy Study Group (IADPSG) diagnostic criteria of gestational diabetes mellitus (GDM) and their associated maternal and neonatal outcomes. Horm Mol Biol Clin Investig. 2018 Feb 17;34(1). pii: /j/hmbci.2018.34.issue-1/hmbci-2017–0077/ hmbci-2017–0077.xml. doi: 10.1515/hmbci-2017–0077.
  15. Cristina B., Giovanni G., Matilde R., Michele A., Lorella B., Prato Stefano D., Alessandra B. Pre-pregnancy obesity, gestational diabetes or gestational weight gain: which is the strongest predictor of pregnancy outcomes? Diabetes Res Clin Pract. 2018 Sep 3. pii: S0168–8227(18)30972–0. doi: 10.1016/j.diabres.2018.08.019.
  16. Lar’kin D. M. Optimizaciya akusherskih i perinatal’nyh iskhodov u pacientok s gestacionnym saharnym diabetom. Diss. kand. med. nauk [Optimization of obstetric and perinatal outcomes in patients with gestational diabetes mellitus. Ph D. med. sci. diss.]. Yekaterinburg, 2016. 114 p.
  17. Lysenko S. N., Chechneva M. A., Petrukhin V. A., Burumkulova F. F., Ermakova L. B. Ultrasound diagnosis of diabetic fetopathy. Russian Bulletin of Obstetrician-Gynecologist. 2016; 3 (16): 23–30 (in Russ).
  18. Akhmetova E. S., Lareva N. V., Mudrov V. A., et al. Features of pregnancy with gestational diabetes mellitus and prediction of diabetic fetopathy. Journal of Obstetrics and Women’s Diseases. 2017;66(4):14–24 (in Russ).
  19. Deryabina E. C., Yakornova G. V., Pestryaeva L. A., Sandyreva N. D. Premature labor in patients with gestational diabetes mellitus. Russian Bulletin of Obstetrician-Gynecologist. 2017; 3 (17): 27–32 (in Russ).
  20. Pivovarova O., Gögebakan Ö., Sucher S., Groth J., Murahovschi V., Kessler K., Osterhoff M., Rudovich N., Kramer A., Pfeiff er A. F. Regulation of the clock gene expression in human adipose tissue by weight loss. Int J Obes (Lond). 2016 Jun; 40(6): 899–906. doi: 10.1038/ijo.2016.34. Epub 2016 Feb 23.
  21. Lan T., Morgan D. A., Rahmouni K., Sonoda J., Fu X., Burgess S. C., Holland W. L., Kliewer S. A., Mangelsdorf D. J. FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia. Cell Metab. 2017 Nov 7; 26(5):709–718.e3. doi: 10.1016/j.cmet.2017.09.005.
  22. Stamatouli A.M., Quandt Z., Perdigoto A. L., Clark P. L., Kluger H., Weiss S. A., Gettinger S., Sznol M., Young A., Rushakoff R., Lee J., Bluestone J. A., Anderson M., Herold K. C. Diabetes. Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors. Diabetes. 2018 Aug; 67(8):1471–1480. doi: 10.2337/dbi18–0002.
  23. Petry C.J., Koulman A., Lu L., Jenkins B., Furse S., Prentice P., Matthews L., Hughes I. A., Acerini C. L., Ong K. K., Dunger D. B. Associations between the maternal circulating lipid profi le in pregnancy and fetal imprinted gene alleles: a cohort study. Reprod Biol Endocrinol. 2018 Aug 29;16(1):82. doi: 10.1186/s12958–018–0399-x.
  24. Simpson S., Smith L., Bowe J. Placental peptides regulating islet adaptation to pregnancy: clinical potential in gestational diabetes mellitus.Curr Opin Pharmacol. 2018 Sep 7;43:59–65. doi: 10.1016/j.coph.2018.08.004.
  25. Nikonova T. V., Vityazeva l. l., Pekareva E. V., Barmina 1.1., Alekseeva YU.V., Shestakova M. V. Th e successful in vitro fertilization in the patient with type 1 diabetes on insulin pump therapy (a case report). Russian Journal of Human Reproduction. 2015; 3(21): 75–80 (in Russ).
  26. Borovik N. V., Potin V. V., Rutenburg E. L. Diabeticheskie mikrososudistye oslozhneniya (retinopatiya i nefropatiya) i beremennost’ [Diabetic microvascular complications (retinopathy and nephropathy) and pregnancy]. Zhurnal akusherstva i zhenskih boleznej – [Journal of obstetrics and women’s diseases], 2013, V. LXII, pp. 75–82 (in Russ).
  27. Bender W., Hirshberg A., Levine L. D. Interpregnancy Body Mass Index Changes: Distribution and Impact on Adverse Pregnancy Outcomes in the Subsequent Pregnancy. Am J Perinatol. 2018 Sep 7. doi: 10.1055/s-0038– 1670634.
  28. Vieira M.C., Begum S., Seed P. T., Badran D., Briley A. L., Gill C., Godfrey K. M., Lawlor D. A., Nelson S. M., Patel N., Sattar N., White S. L., Poston L., Pasupathy D. UPBEAT Consortium. Gestational diabetes modifi es the association between PlGF in early pregnancy and preeclampsia in women with obesity. Pregnancy Hypertens. 2018 Jul; 13:267–272. doi: 10.1016/j.preghy.2018.07.003.
  29. Huet J., Beucher G., Rod A, Morello R., Dreyfus M. Joint impact of gestational diabetes and obesity on perinatal outcomes. J Gynecol Obstet Hum Reprod. 2018 Aug 25. pii: S2468–7847(18)30217–4. doi: 10.1016/j.jogoh.2018.08.003.
  30. Reichelt A.J., Weinert L. S., Mastella L. S., Gnielka V., Campos M. A., Hirakata V. N., Oppermann M. L.R., Silveiro S. P., Schmidt M. I. Clinical characteristics of women with gestational diabetes – comparison of two cohorts enrolled 20 ears apart in southern Brazil. Sao Paulo Med J. 2017 Jul-Aug;135(4):376–382. doi: 10.1590/1516– 3180.2016.0332190317.
  31. Collins K., Oehmen R., Mehta S. Eff ect of obesity on neonatal hypoglycaemia in mothers with gestational diabetes: A comparative study. Aust. N. Z. J. Obstet Gynaecol. 2017: 13. DOI: 10. 1111/ajo.12717.
  32. Moen G.H., Sommer C., Prasad R. B., Sletner L., Groop L., Qvigstad E., Birkeland K. I. Mechanisms in endocrinology: Epigenetic modifi cations and gestational diabetes: a systematic review of published literature. Eur J Endocrinol. 2017 May; 176(5): R247-R267. doi: 10.1530/ EJE-16–1017.
  33. Abell S.K., De Courten B., Boyle J. A., Teede H. J. Infl ammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus. Int J Mol Sci. 2015 Jun 11; 16 (6): 13442–73. doi: 10.3390/ ijms160613442.
  34. Sureshchandra S., Marshall N. E., Wilson R. M., Barr T., Rais M., Purnell J. Q., Th ornburg K. L., Messaoudi I. Infl ammatory Determinants of Pregravid Obesity in Placenta and Peripheral Blood. Front Physiol. 2018 Aug 7;9:1089. doi: 10.3389/fphys.2018.01089.
  35. Miehle K., Stepan H., Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf). 2012 Jan;76(1):2–11. doi: 10.1111/j.1365–2265.2011.04234.x.
  36. Fasshauer M., Blüher M., Stumvoll M. Adipokines in gestational diabetes. Lancet Diabetes Endocrinol. 2014 Jun;2(6):488–99. doi: 10.1016/S2213–8587(13)70176–1.
  37. Retnakaran R., Ye C., Hanley A. J., Connelly P. W., Sermer M., Zinman B., Hamilton J. K. Eff ect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational diabetes mellitus. CMAJ. 2012 Sep 4; 184(12):1353–60. doi: 10.1503/cmaj.111154.
  38. Korkmazer E., Solak N. Correlation between inflammatory markers and insulin resistance in pregnancy. J Obstet Gynaecol. 2015 Feb;35(2):142–5. doi: 10.3109/01443615.2014.948408.
  39. Herrera E., Ortega-Senovilla H. Lipid metabolism during pregnancy and its implications for fetal growth. Curr Pharm Biotechnol. 2014; 15(1): 24–31.
  40. Yanai S., Tokuhara D., Tachibana D., Saito M., Sakashita Y., Shintaku H., Koyama M. Diabetic pregnancy activates the innate immune response through TLR5 or TLR1/2 on neonatal monocyte. J Reprod Immunol. 2016 Sep;117:17–23. doi: 10.1016/j.jri.2016.06.007.
  41. Shaposhnikova E. V., Vedmed A. A., Batchinina O. V. Th e eff ects of gestational diabetes on pregnancy and the neonate: complication and outcomes in births. Smolensk medical almanac. 2017; 4: 57–60 (in Russ).
  42. Aksenov A. N., Bocharova I. I., Bashakin N. F., Troitskaya M. V., Yakubina A. A., Burumkulova F. F., Guryeva V. M. Specifi c features of early postnatal adaptation and management of neonates born to mothers with gestational diabetes mellitus. Russian Bulletin of Obstetrician-Gynecologist. 2015; 4: 75–80 (in Russ).
  43. Nikitina I. L., Konoplya I. S., Polyanskaya A. A., Liskina A. S., Popova P. V. Characterization of psychological and physical development in children of gestation diabetes pregnancies. Meditsinsky Sovet. 2017; 9: 14–20 (in Russ).
  44. Derraik J.G., Ayyavoo A., Hofman P. L., Biggs J. B., Cutfi eld W. S. Increasing maternal prepregnancy body mass index is associated with reduced insulin sensitivity and increased blood pressure in their children. Clin Endocrinol (Oxf). 2015 Sep;83(3):352–6. doi: 10.1111/cen.12665.
  45. Wang J., Pan L., Liu E., Liu H., Liu J., Wang S., Guo J., Li N., Zhang C., Hu G. Gestational diabetes and off spring’s growth from birth to 6 years old. Int J Obes (Lond).2018 Sep 4.doi: 10.1038/s41366–018–0193-z.
  46. Antikainen L., Jääskeläinen J., Nordman H., Voutilainen R., Huopio H. Prepubertal Children Exposed to Maternal Gestational Diabetes Have Latent Low-Grade Infl ammation. Horm Res Paediatr. 2018 Aug 15:1–7.doi: 10.1159/000491938.
  47. Kawasaki M., Arata N., Miyazaki C., Mori R., Kikuchi T., Ogawa Y., Ota E. Obesity and abnormal glucose tolerance in off spring of diabetic mothers: A systematic review and meta-analysis. PLoS One. 2018 Jan 12; 13(1): e0190676. doi: 10.1371/journal.pone.0190676.
  48. Patro Golab B., Santos S., Voerman E., Lawlor D. A., Jaddoe V. W.V., Gaillard R. MOCO Study Group Authors. Infl uence of maternal obesity on the association between common pregnancy complications and risk of childhood obesity: an individual participant data meta-analysis. Lancet Child Adolesc Health.2018 Sep 7.pii: S2352– 4642(18)30273–6. doi: 10.1016/S2352–4642(18)30273–6
  49. Shanina O. M., Mikhalev E. V., Saprina T. V. Hemostasis regulation and metabolic (hormonal, electrolyte) disturbances in term newborns from women with gestational diabetes. Diabetes Mellitus. 2015; 1: 78–86
  50. Bellatore A., Scherzinger A., Stamm E., Martinez M. et al. Fetal ovemutrition and adolescent hepatic fat fraction: the exploring perinatal outcomes in children study. J. Pediatr. 2017 Oct 15. pii: S0022–3476(l7)31169–1. DOI: 10.1016/j. jpeds.2017.09.008.
  51. Li S., Zhu Y., Yeung E., Chavarro J. E., Yuan C., Field A. E., Missmer S. A., Mills J. L., Hu F. B., Zhang C. Off spring risk of obesity in childhood, adolescence and adulthood in relation to gestational diabetes mellitus: a sex-specifi c association. Int J Epidemiol. 2017 Oct 1; 46(5):1533–1541. doi: 10.1093/ije/dyx151.
  52. Nikitin A. G., Potapov V. A., Brovkin, Lavrikova E. Y., Khodyrev D. S., Shamhalova M. Sh., Smetanina S. A., Suplotova A. N., Shestakova M. V., Nosikov V. V., Averyanov A. V. Association of the polymorphisms of the FTO, KCNJ11, SLC30A8 and CDKN2B genes with type 2 diabetes. Molecular Biology. 2015; 1 (49): 119–128 (in Russ).

Full text is published :
Papysheva O. V., Kharitonov L. A., Kotaysh G. A., Shurygina D. A. Lipid and carbohydrate exchanges in children born to mothers with gestational diabetes mellitus. Experimental and Clinical Gastroenterology. 2019;161(1): 137–144. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-137-144
Read & Download full text

1. North-West State Medical University. I. I. Mechnikova of the Ministry of Health of the Russian Federation, St. Petersburg 191015, Russia
2. Children’s Research Orthopedic Institute named after G. I. Turner of the Ministry of Health of the Russian Federation, St. Petersburg 196603, Russia
3. St. Petersburg Research Institute of Phthisiopulmonology of the Ministry of Health of the Russian Federation, St. Petersburg 191036, Russia
4. Biobank Center of St. Petersburg State University, St. Petersburg 198504, Russia

Keywords: children, hereditary diseases, dysmorphia, Loeys-Dietz syndrome, NGS (next generation sequencing) technology

Abstract:The article discusses the diagnostic strategy of search and application of modern methods of molecular genetics in the diagnosis of hereditary diseases. The approach of molecular genetic diagnosis using NGS technology (new-generation sequencing). At the clinical example of the patient with Lois-Dietz syndrome, type 2 is shown the signifi cance for diagnosis method of target sequencing of DNA sites relating to the coding areas of the genes associated with contractural arachnodactyly, Marfan’s syndrome and other hereditary diseases with similar phenotypical manifestations.

• References total 16 ⇓ :: .
  1. Asanov A. Yu., Demikova N. S., Golimbet V. E. Basics of genetics. Moscow, Academy Publ., 2012.
  2. Larionova V. I., Khramtsova E. G., Nikitina A. P., Bulatnikova M. A., Kostik M. M., Melnikova I. Yu., Vissarionov S. V. Diagnosis and treatment of hereditary metabolic diseases with skeletal lesions in the practice of an orthopedist and pediatrician: a manual for doctors. SPb. LLC SPB-SRP “Pavel” VOG. Publ. 2017.
  3. Seo Go Hum, Kim Yoon-Myung, Kang Eungu, Kim GuHwan, Seo Eul-Ju, Beom Hee Lee, Choi Jin-Ho, Yoo HanWook. Th e phenotypic heterogeneity of patients with Marfan-related disorders and their variant spectrums. Medicine Baltimore. 2018; 97(20): 107–67.
  4. Lerner-Ellis J.P., Aldubayan S. H., Hernandez A. L., Kelly M. A., Stuenkel A. J., Walsh J., Joshi V. A. Th e spectrum of FBN1, TGFbetaR1, TGFbetaR2 and ACTA2 variants in 594 individuals with suspected Marfan syndrome, Loeys-Dietz syndrome or Th oracic Aortic Aneurysms and Dissections (TAAD). Mol Genet Metab. 2014; 112(2):171–6.
  5. van de Laar I. M., Oldenburg R. A., Pals G., Roos-Hesselink J.W., de Graaf B. M., Verhagen J. M., Hoedemaekers Y. M., Willemsen R., Severijnen L. A., Venselaar H., Vriend G., Pattynama P. M., Collee M., Majoor-Krakauer D., Poldermans D., Frohn-Mulder I.M., Micha D., Timmermans J., Hilhorst-Hofstee Y., Bierma-zeinstra S.M., Willems P. J., Kros J. M., Oei E. H., Oostra B. A., Wessels M. W., Bertoli-Avella A. M. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nature genetics. 2011; 43 (2): 121–6.
  6. Loeys B. L., Schwarze U., Holm T., Callewaert B. L., Th omas G. H., Pannu H., De Backer J. F., Oswald G. L., Symoens S., Manouvrier S., Roberts A. E., Faravelli F., Greco M. A., Pyeritz R. E., Milewicz D. M., Couke P. J., Cameron D. E., Braverman A. C., Byers P. H., De Paepe A. M., Dietz H. C. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006; 355(8): 788–98.
  7. Attias D., Stheneur C., Roy C., Collod-Beroud G., Detaint D., Faivre L., Delrue M. A., Cohen L., Francannet C., Beround C., Claustres M., Iserin F., Khau Van Kien P., Lacombe D., Le Merrer M., Lyonnet S., Odent S., Plauchu H., Rio M., Rossi A., Sidi D., Steg P. G., Ravaud P., Boileau C., Jondeau G. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation. 2009; 120(25): 2541–2549.
  8. MacCarrick Gretchen, Black III James H., Bowdin Sarah, El-Hamamsy Ismail, Frischmeyer-Guerrerio Pamela A., Guerrerio Anthony L., Sponseller Paul D., Loyes Bart, Dietz III Harry C. Loeys-Dietz syndrom a primer for diagnosis and management. Genetics in Medicine. 2014; 16: 576–587.
  9. Hardwick Simon A., Deveson Ira W., Mercer Tim R. Reference standards for next-generation sequencing. Nat Rev Genet. 2017; 18(8): 473–484.
  10. Raff an E., Semple R. K. Next generation sequencing – implications for clinical practice. British Medical Bulletin. 2011; 99: 53–71.
  11. de Koning T. J., Jongbloed J. D., Sikkema-Raddatz B., Sinke R. J. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges. Expert Rev Mol Diagn. 2015; 15(1): 61–70.
  12. Shashi V., McConkie-Rosell A., Rosell B., Shock K., Vellore K., McDonald M., Jiang Y. H., Xie P., Need A., Goldetein D. B. Th e utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders. Genet Med. 2014; 16(2): 176–82.
  13. Di Resta Chiara, Galbiati Silvia, Carrera Paola, Ferrari Maurizio. Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities Journal of the International Federation of Clinical Chemistry and Laboratory Medicine. 2018; 29(1): 4–14.
  14. Richards Sue, Aziz Nazneen, Bale Sherri, Bick David, Das Soma, Gastier-Foster Julie, GrodyWayne W., Hegde Madhuri, Lyon Elaine, Elaine Spector Elaine, Voelkerding Karl, Rehm Heidi L. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405–424.
  15. Santani Avni, Murrell Jill, Funke Birgit, Yu Zhenming, Hegde Madhuri, Mao Rong, Ferreira-Gonzalez Andrea, Voelkerding Karl V., Weck K. E. Development and validation of targeted next-generation sequencing panels for detection of germline variants in inherited diseases. Archives of Pathology and Laboratory Medicine. 2017; 141(6): 787–797.
  16. Suspitsin E. N., Tyurin V. I., Imyanitov E. N., Sokolenko A. P. Whole exome sequencing: principles and diagnostic capabilities, Russian Journal of Pediatrician (St Petersburg), 2016;7(4):142–146 doi.org/10.17816/PED74142–146

Full text is published :
Larionova V. I., Khramtsova E. G., Nikitina A. P., Serebryakova E. A., Melnikova I. Yu. New molecular-genetic technologies in diff erential diagnostics of orfan diseases in children. Experimental and Clinical Gastroenterology. 2019;161(1): 145–149. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-145-149
Read & Download full text

1. Saratov State Medical University, n. a. V. I. Razumovsky of the Ministry of Health of Russia, Saratov 410012, Russia

Keywords: Langerhans cell hystiocytosis, Langerhans cell, hemocolitis

Abstract:The article presents a brief information about Langerhans cell hystiocytosis — a rare granulomatous proliferative disease in which there is an infi ltration of one or more organs by Langerhans cells. A detailed description of the clinical case of this disease in a child of the fi rst year of life with a rare variant of the onset of the disease in the form of a severe hormone-dependent lesion of the colon, which occurred with the leading symptom of hemocolitis.

• References total 15 ⇓ :: .
  1. Elkin V. D., Sedova T. G., Kopytova E. A., Plotnikova E. V. Langerhans cell histiocytosis: Skin diseases and visceral lesions. Ter Arkh. 2017, vol.89, no.4, pp.115–120. doi: 10.17116/terarkh2017894115–120
  2. Badalian-Very G., Vergilio J. A., Fleming M., Rollins B. J. Pathogenesis of Langerhans cell histiocytosis. // Annu. Rev. Pathol. – 2013, 8.-р.1–20. doi:10.1146/annurev-pathol-020712–163959
  3. Egeler R.M., Nesbit M. E. Langerhans cell histiocytosis and other disorders of monocyte-histiocyte lineage// Crit. Rev. Oncol Hematol.-1995.-18(1). – р.9–35. doi: 10.1016/1040–8428(94)00117-C
  4. Coppes-Zantiga A., Egeler R. M. Th e Langerhans cell histiocytosis X fi les revealed// Br J Haematol. – 2002.116(1).-р.3–9. doi:10.1046/j.1365–2141.2002. 03232.x
  5. Samsonov V. A., Chistyakov I. A., Goryacheva T. A. Normal cholesteremic xanthomatosis as a rare case of cholesterol thesaurismosis. Vestnik Dermatologii i Venerologii. 2009, no.2, pp.54–59.
  6. Novichkova G. A., Minkov M., Maschan M. A., Chernov V. M. Gistiocitosis. [Clinical Oncohematology: Guide for Physicians. Ed. M. A. Volkova], Moscow, Medicine, 2007, pp. 891–911.
  7. Swerdlow S.H., Campo E., Harris N. L.et al. WHO Classifi cation of Tumours of Haematopoietic and Lymphoid Tissues. 4th Ed. International Agency for Research on Cancer. – Lyon. – 2008.-P.439.
  8. Ng-Cheng-Hin B., о’Hanlon-Brown C., Alifrangis C., Waxman J. Langerhans cell histiocytosis: old disease new treatment// Q J Med.-2011.-104(2).-р.89–96.
  9. Dolgov V. A., Anikin M. I., Gorbaneva G. A., Chesnokov V. P., Makaev F. Kh., Shapochnik A. P. Th e case of detection of histiocytosis in nursing infant primarily diagnosed as serous infl ammation of middle ear. Russian Otorhinolaryngology. 2016, vol.80, no.1, pp. 112–114. doi: 10.18692/1810–4800–2016–1–112–115.
  10. Djadkin V. Ju., Abdrahmanov R. M. Th e case of histiocytosis from Langerhans cells. Prakticheskaja medicina. 2011, no.2, pp.11–12.
  11. Odinets Y. V., Poddubnaya I. N., Panfilova E. A., Afanasieva O. A. Difficulties of diff erential diagnostics of Langerhance cells’ histiocytosis in children. Pathologia. 2011, vol.8, no.1, pp. 86–87.
  12. Hurwjtz L. Clinical pediatric dermatology. Fours edition. Elsevier saunders, 2011. P. 286.
  13. Satter E.K., High W. Q. Langerhans cell histiocytosis: a review of the current recommendations of the Histiocyte Society// Pediatr Dermatol.-2008.-25(3). – р.291–295. doi:10.1111/j.1525–1470.2008.00669.x
  14. Rumiantcev A. G., Maschan A. A., Maschan M. A., Novichkova G. A. Federalnie klinicheskie rekomendacii po diagnostike i lecheniyu gistiocytosa iz kletok Langergansa [Federal clinical guidelines for the diagnosis and treatment of histiocytosis from Langerhans cells]. Moscow, NODGO, 2015. 39 p.
  15. Valiev T. T., Makhonova L. A., Kovrigina A. M., Sholokhova E. N., Tupitsyn N. N., Serebryakova I. N., Mentkevich G. L. Case of congenital Langerhans cells histiocytosis in an infant. Oncohematology. 2011, no.2, pp.19–23.

Full text is published :
Spivakovskiy Yu. M., Spivakovskaya A. Yu., Chernenkov Yu. V. Langerhans cell hystiocytosis in a child with a heavy hemocolitis. Experimental and Clinical Gastroenterology. 2019;161(1): 150–154. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-150-154
Read & Download full text

1. N. I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia

Keywords: peptic ulcer, history of medicine, Helicobacter pylori, antisekretornaja therapy, selective proximal vagotomy

Abstract:This article describes the historical information about advances in the study of peptic ulcer in historical context. Submitted to the dramatic collision of diff erent theories of occurrence ulcers. Examples from the study of diagnosis, treatment and prevention of ulcers shows the dialectics of scientifi c and clinical progress both in our country and abroad. Special attention is paid to ulcers in children, because historically that the issue in the USSR and Russia became studied earlier and at a higher level. Endoscopic examinations of children in our country have been put in place much earlier, which allowed based on the results of years of research to formulate appropriate recommendations and prepare highly qualifi ed specialists. Particular attention is paid to the success of surgery in the treatment of peptic ulcer disease, the role of Helicobacter pylori in Genesis of ulcers. The results presented in the article clear understanding the achievements of medical practice practitioners have managed to improve the quality of life of patients with peptic ulcer and signifi cantly reduce their disablement. .

• References total 29 ⇓ :: .
  1. Samsonov V. А. Рeptic ulcer disease. New materials of pathomorphology of complicated forms. Petrozavodsk: Karelia, 1975.-260 р.
  2. Modlin I.M., Sachs G. Acid related diseases/ Biology and treatment. Schnetztor-Verlag GmbH D-Konstanz, 1998: 365 p.
  3. Ivashkin V. T. School clinician. Peptic ulcer-history of medicine. Medical bulletin. 2006. No. 19 (362): 9–10.
  4. Gastroenterology. Adult disease. Ed. L. B. Lazebnik, P. L. Shcherbakova. M.: Edition of medical books, 2011: 480 p.
  5. Ivashkin V. T. Maigrot F., Lapina T. L. Helicobacter pylori: a revolution in gastroenterology. M.: Triada, 1999:255 p.
  6. Mayev I.V, Samsonov A. A., Andreev, D. N. Infection Helicobacter pylori. -М.: Geotar-media, 2016, –250 p.
  7. Goodwin C. S., Armstrong J. A. Microbiological aspects of Helicobacter pylori (Campylobacter pylori)// Eur.J.Clin. Microbiol.Dis. 1990. Vol.9: 1–13.
  8. Malfertheiner P., Megraud F., O’Morain C.A. et al. Management of Helicobacter pylori Infection – the Maastricht-V. Florence Consensus Report.// Gut. 2017; 66 (1): 6–30.
  9. Tsukanov V. V., Kasparov E. V., Vasyutin A. V., Tonkich Y. L. Possible applications of probiotics for Helicobacter pylori infection: recommendations of the Congress Maastricht V//Physician. 2017. 1:17–19.
  10. Shchegolev A. A., Titkov B. E. Helicobacter pylori and peptic ulcer surgery. M.: MegaPro, 2004: 264 p.
  11. Gubergriz M. M. To clinic ulcers (1949). Selected works. – Kiev, 1959. -C. 337–352.
  12. Radbil O. S. Peptic ulcer and its treatment. Kazan, 1969.
  13. Kornienko E. A. Helicobacter pylori Infection in children. M.: GEOTAR-Media, 2011: 272.
  14. Lazebnik L. B. Standards of diagnostics and treatment of kislotozavisimych diseases associated with Helicobacter pylori//Experimental and clinical gastroenterology. 2010. 5:113–120.
  15. Loginov A. S., Aruin L. I., Ilchenko A. A. Peptic ulcer disease and Helicobacter pylori. New aspects of the pathogenetic therapy. Moscow, CNIIG, 1993, 240 p.
  16. Scherbakov P. L., Korsunsky A. A. Helicobacter pylori infection and gastroduodenal diseases in children. Moscow, Medpraktika-M Publ., 2003, 300 p.
  17. Bakulev A. I. Vagotomy in the stomach ulcer. Ter. arch. 1949, no. 2, pp. 93–94.
  18. Berezov E. L. Surgery of the stomach and duodenum. Gorkiy: Gorkovs Medical Institute, 1950:232.
  19. Busalov A. A. Gastrectomy with peptic ulcer disease (in the light of the remote results). Moscow, Medgiz, 1951:164 p.
  20. Yudin S. S. Studies of gastric surgery. Moscow, MEDGIZ, 1955:264 p.
  21. Savelyev V. S., Beriozoff Yu. B. Some aspects of surgery of chronic gastric ulcer and duodenal ulcer//Surgery. 1975. 4: 3–7.
  22. Fedorov E. D. Endoscopic intervention in treating ulcerative gastroduodenal hemorrhage. Moscow, 2002, 48 p.
  23. Peptic ulcer disease in children (clinical picture, diagnosis, treatment, prevention): methodical recommendations/Edited by A. V. Mazurin. Moscow, GUZM. Publ., 1975, 50 p.
  24. Grigoriev, K.I., Zaprudnov A. M., Kharitonova L. A. Peptic ulcer disease: from Hippocrates to the present day. Medical Nurse. 2016, 6, 48–51.
  25. Tsvetkova L. N. Duodenal ulcer in children – a look from a position of 30 years of studying the problem//Vopr. child nutrition. 2004. 2 (2): 37–43.
  26. Paramonov A. A., Volkov A. I. Indications for surgical treatment of duodenal ulcers in children//Pediatrics. 1983. No. 10:53–54.
  27. Grigoryev P. Y. Diagnosis and treatment of gastric ulcer and duodenal ulcer. M.: Medicine, 1986:224 p.
  28. Zimmerman Y. S. Peptic ulcer: а сritical analysis of modern state of the problem. Experimental and Clinical Gastroenterology. 2018; 149 (1): 80–89.
  29. Khorobrykh T. V. Scorpion in the stomach. Talk about ulcers with a surgeon-gastrojenterologist. Article published on the site http://www.gastroscan.ru

Full text is published :
: Grigorуev K. I., Zaprudnov А. M., Kharitonova L. A. Peptic ulcer disease — historical dynamics: views on etiopathogenesis and treatment from a position of pediatricians. Experimental and Clinical Gastroenterology. 2019;161(1): 155–165. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-155-165
Read & Download full text

1. FDO FGBOU “Russian Research Medical University, named after N. I. Pirogov” of Ministry of Health of Russia, Moscow, Russia

Abstract: The article is devoted to the 30th anniversary of the Department of Pediatrics with Infectious Diseases in Children of the Russian National Research University. N. I. Pirogov Ministry of Health of Russia, to the history of the formation and development of the department. Many scientifi c works and research directions present the priority and importance for modern science and practical healthcare. The structure of clinical bases, and therapeutic activity are described. Highlighted the Fragments of the department’s tight cooperation with both in personnel training and in medical work with the health authorities of various regions of Russia. Outlined future prospects of the departments’ activity.

Full text is published :
Grigorуev K. I. Thirty-years experience of teaching pediatrics with infectious diseases at the pediatrics with infectious diseases department of Russian Research Medical University, named after N. I. Pirogov. Experimental and Clinical Gastroenterology. 2019;161(1): 166–169. (In Russ.) DOI: 10.31146/1682-8658-ecg-161-1-166-169
Read & Download full text